Reported covered position: Counsel, U.S. House of Representatives, Committee on Energy and Commerce
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Fairness in Orphan Drug Exclusivity Act
Client: BIOMARIN PHARMACEUTICAL INC. · Firm: CHAMBER HILL STRATEGIES
Issues generally related to biopharmaceutical drugs and drug development programs, including, but not limited to: Orphan Drug Act incentives, including H.R. 1629/S.250, the Fairness in Orphan Drug Exclusivity Act; drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021; access to rare disease and gene therapy drugs; FDA approvals of drugs designed to treat rare diseases, including gene therapies; and regulatory reforms generally, including but not limited to S. 3799, the PREVENT Pandemics Act, H.R. 6000, CURES 2.0, H.R. 6963, the Accelerated Approval Integrity Act of 2022, H.R. 6996, the Accelerating Access for Patients Act. Issues pertaining to newborn screening and gene panel screening, including provisions of H.R. 482/S.350 , the Newborn Screening Saves Lives Reauthorization Act of 2021. Policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SANFORD HEALTH via CHAMBER HILL STRATEGIES
2023 · second_quarter · 2A
Policies that affect hospitals, skilled nursing facilities, and health systems
Policies impacting access to pharmacogenomic testing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| NATIONAL PARTNERSHIP FOR WOMEN AND FAMILIES | 9 | 2020–2022 |
| Sanford Health | 9 | 2021–2023 |
| AMERICAN RENAL ASSOCIATES | 8 | 2019–2021 |
| COMMONWEALTH CARE ALLIANCE | 8 | 2017–2019 |
| U.S. RENAL CARE | 8 | 2017–2019 |
| SAGHMOS THERAPEUTICS, INC. | 7 | 2020–2021 |
| FREQUENCY THERAPEUTICS INC. | 5 | 2020 |
| HEALTH AND HOSPITALS, INC. | 5 | 2019–2020 |
| COVENANT HEALTHCARE | 4 | 2020–2021 |
| AKEBIA THERAPEUTICS, INC. | 3 | 2018 |
| CIC HEALTH | 3 | 2022–2023 |
| MEDICAID HEALTH PLANS OF AMERICA | 3 | 2022–2023 |
| PEAK INTERNATIONAL PARTNERS LLC | 2 | 2021 |
| WELLCARE HEALTH PLANS, INC. | 2 | 2017–2019 |
| NATIONAL ASSOCIATION FOR THE SUPPORT OF LONG TERM CARE | 1 | 2017 |
| THERAPEUTICSMD, INC. | 1 | 2017 |
Fairness in Orphan Drug Exclusivity Act
Client: BIOMARIN PHARMACEUTICAL INC. · Firm: CHAMBER HILL STRATEGIES
Issues generally related to biopharmaceutical drugs and drug development programs, including, but not limited to: Orphan Drug Act incentives, including H.R. 1629/S.250, the Fairness in Orphan Drug Exclusivity Act; drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021; access to rare disease and gene therapy drugs; education and awareness of genetic rare bone disorders; FDA approvals of drugs designed to treat rare diseases, including gene therapies; and regulatory reforms generally, including but not limited to S. 3799, the PREVENT Pandemics Act, H.R. 6000, CURES 2.0, H.R. 6963, the Accelerated Approval Integrity Act of 2022, H.R. 6996, the Accelerating Access for Patients Act; H.R. 7667, Food and Drug Amendments of 2022, and S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act. Issues pertaining to newborn screening and gene panel screening, including provisions of H.R. 482/S.350 , the Newborn Screening Saves Lives Reauthorization Act of 2021. Policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021.
Fairness in Orphan Drug Exclusivity Act
Client: BIOMARIN PHARMACEUTICAL INC. · Firm: CHAMBER HILL STRATEGIES
Issues generally related to biopharmaceutical drugs and drug development programs, including, but not limited to: Orphan Drug Act incentives, including H.R. 1629/S.250, the Fairness in Orphan Drug Exclusivity Act; drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021; access to rare disease and gene therapy drugs; education and awareness of genetic rare bone disorders; FDA approvals of drugs designed to treat rare diseases, including gene therapies; and regulatory reforms generally, including but not limited to S. 3799, the PREVENT Pandemics Act, H.R. 6000, CURES 2.0, H.R. 6963, the Accelerated Approval Integrity Act of 2022, H.R. 6996, the Accelerating Access for Patients Act; H.R. 7667, Food and Drug Amendments of 2022, and S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act. Issues pertaining to newborn screening and gene panel screening, including provisions of H.R. 482/S.350 , the Newborn Screening Saves Lives Reauthorization Act of 2021. Policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021; P.L. 117-169, Inflation Reduction Act.
Fairness in Orphan Drug Exclusivity Act
Client: BIOMARIN PHARMACEUTICAL INC. · Firm: CHAMBER HILL STRATEGIES
Issues generally related to biopharmaceutical drugs and drug development programs, including, but not limited to: Orphan Drug Act incentives, including H.R. 1629/S.250, the Fairness in Orphan Drug Exclusivity Act; drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021; access to rare disease and gene therapy drugs; education and awareness of genetic rare bone disorders; FDA approvals of drugs designed to treat rare diseases, including gene therapies; and regulatory reforms generally, including but not limited to S. 3799, the PREVENT Pandemics Act, H.R. 6000, CURES 2.0, H.R. 6963, the Accelerated Approval Integrity Act of 2022, H.R. 6996, the Accelerating Access for Patients Act; H.R. 7667, Food and Drug Amendments of 2022, and S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act. Issues pertaining to newborn screening and gene panel screening, including provisions of H.R. 482/S.350 , the Newborn Screening Saves Lives Reauthorization Act of 2021. Policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021; P.L. 117-169, Inflation Reduction Act.
Dr. Lorna Breen Health Care Provider Protection Act
Client: SOCIETY OF HOSPITAL MEDICINE · Firm: CHAMBER HILL STRATEGIES
H.R. 1384/S. 445, the Mainstreaming Addiction Treatment Act of 2019; H.R. 1667, Dr. Lorna Breen Health Care Provider Protection Act/ P.L. 117- 71, Protecting Medicare and American Farmers from Sequester Cuts Act; issues generally pertaining to the impact of COVID on hospitalists.
Lower Costs, More Cures Act of 2021
Client: BIOMARIN PHARMACEUTICAL INC. · Firm: CHAMBER HILL STRATEGIES
Issues generally related to biopharmaceutical drugs and drug development programs, including but not limited to drug pricing proposals, Medicaid payments, access to treatment through telehealth, and access to rare disease and gene therapy drugs. Policies contained in drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021. Policies contained in 85 FR 87000, Medicaid Program; Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements. H.R. 7489, Medicaid VBPs for Patients Act or the MVP Act.
Lower Costs, More Cures Act of 2021
Client: BIOMARIN PHARMACEUTICAL INC. · Firm: CHAMBER HILL STRATEGIES
Issues generally related to biopharmaceutical drugs and drug development programs, including but not limited to drug pricing proposals, Medicaid payments, access to treatment through telehealth, and access to rare disease and gene therapy drugs. Policies contained in drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021, and in H.R.3684 - Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act. Policies contained in 85 FR 87000, Medicaid Program; Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements. H.R. 7489, Medicaid VBPs for Patients Act or the MVP Act.
Lower Costs, More Cures Act of 2021
Client: BIOMARIN PHARMACEUTICAL INC. · Firm: CHAMBER HILL STRATEGIES
Issues generally related to biopharmaceutical drugs and drug development programs, including, but not limited to: Orphan Drug Act incentives, including H.R. 1629/S.250, the Fairness in Orphan Drug Exclusivity Act; drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021; access to rare disease and gene therapy drugs; FDA approvals of drugs designed to treat rare diseases, including gene therapies; and regulatory reforms generally, including but not limited to S. 3799, the PREVENT Pandemics Act, H.R. 6000, CURES 2.0, H.R. 6963, the Accelerated Approval Integrity Act of 2022, H.R. 6996, the Accelerating Access for Patients Act. Issues pertaining to newborn screening and gene panel screening, including provisions of H.R. 482/S.350 , the Newborn Screening Saves Lives Reauthorization Act of 2021. Policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021.
Lower Costs, More Cures Act of 2021
Client: BIOMARIN PHARMACEUTICAL INC. · Firm: CHAMBER HILL STRATEGIES
Issues generally related to biopharmaceutical drugs and drug development programs, including, but not limited to: Orphan Drug Act incentives, including H.R. 1629/S.250, the Fairness in Orphan Drug Exclusivity Act; drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021; access to rare disease and gene therapy drugs; education and awareness of genetic rare bone disorders; FDA approvals of drugs designed to treat rare diseases, including gene therapies; and regulatory reforms generally, including but not limited to S. 3799, the PREVENT Pandemics Act, H.R. 6000, CURES 2.0, H.R. 6963, the Accelerated Approval Integrity Act of 2022, H.R. 6996, the Accelerating Access for Patients Act; H.R. 7667, Food and Drug Amendments of 2022, and S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act. Issues pertaining to newborn screening and gene panel screening, including provisions of H.R. 482/S.350 , the Newborn Screening Saves Lives Reauthorization Act of 2021. Policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021; P.L. 117-169, Inflation Reduction Act.
Lower Costs, More Cures Act of 2021
Client: BIOMARIN PHARMACEUTICAL INC. · Firm: CHAMBER HILL STRATEGIES
Issues generally related to biopharmaceutical drugs and drug development programs, including but not limited to drug pricing proposals, Medicaid payments, and access to rare disease and gene therapy drugs. Policies contained in drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021, and in H.R.3684 - Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act. Policies contained in 85 FR 87000, Medicaid Program; Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements.
Lower Costs, More Cures Act of 2021
Client: BIOMARIN PHARMACEUTICAL INC. · Firm: CHAMBER HILL STRATEGIES
Issues generally related to biopharmaceutical drugs and drug development programs, including but not limited to drug pricing proposals, Medicaid payments, access to treatment through telehealth, and access to rare disease and gene therapy drugs. Policies contained in drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021. Policies contained in 85 FR 87000, Medicaid Program; Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements. H.R. 7489, Medicaid VBPs for Patients Act or the MVP Act.
Lower Costs, More Cures Act of 2021
Client: BIOMARIN PHARMACEUTICAL INC. · Firm: CHAMBER HILL STRATEGIES
Issues generally related to biopharmaceutical drugs and drug development programs, including, but not limited to: Orphan Drug Act incentives, including H.R. 1629/S.250, the Fairness in Orphan Drug Exclusivity Act; drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021; access to rare disease and gene therapy drugs; education and awareness of genetic rare bone disorders; FDA approvals of drugs designed to treat rare diseases, including gene therapies; and regulatory reforms generally, including but not limited to S. 3799, the PREVENT Pandemics Act, H.R. 6000, CURES 2.0, H.R. 6963, the Accelerated Approval Integrity Act of 2022, H.R. 6996, the Accelerating Access for Patients Act; H.R. 7667, Food and Drug Amendments of 2022, and S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act. Issues pertaining to newborn screening and gene panel screening, including provisions of H.R. 482/S.350 , the Newborn Screening Saves Lives Reauthorization Act of 2021. Policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021.
Lower Costs, More Cures Act of 2021
Client: BIOMARIN PHARMACEUTICAL INC. · Firm: CHAMBER HILL STRATEGIES
Issues generally related to biopharmaceutical drugs and drug development programs, including, but not limited to: Orphan Drug Act incentives, including H.R. 1629/S.250, the Fairness in Orphan Drug Exclusivity Act; drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021; access to rare disease and gene therapy drugs; education and awareness of genetic rare bone disorders; FDA approvals of drugs designed to treat rare diseases, including gene therapies; and regulatory reforms generally, including but not limited to S. 3799, the PREVENT Pandemics Act, H.R. 6000, CURES 2.0, H.R. 6963, the Accelerated Approval Integrity Act of 2022, H.R. 6996, the Accelerating Access for Patients Act; H.R. 7667, Food and Drug Amendments of 2022, and S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act. Issues pertaining to newborn screening and gene panel screening, including provisions of H.R. 482/S.350 , the Newborn Screening Saves Lives Reauthorization Act of 2021. Policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021; P.L. 117-169, Inflation Reduction Act.
Healthcare Workforce Resilience Act
Client: SOCIETY OF HOSPITAL MEDICINE · Firm: CHAMBER HILL STRATEGIES
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; H.R. 4521, America COMPETES Act of 2022; and policies contained in H.R. 5376, Build Back Better Act.
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; and H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; policies contained in H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14.
Healthcare Workforce Resilience Act
Client: SOCIETY OF HOSPITAL MEDICINE · Firm: CHAMBER HILL STRATEGIES
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; H.R. 4521, America COMPETES Act of 2022; and policies contained in H.R. 5376, Build Back Better Act.
Healthcare Workforce Resilience Act
Client: SOCIETY OF HOSPITAL MEDICINE · Firm: CHAMBER HILL STRATEGIES
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; H.R. 4521, America COMPETES Act of 2022; and policies contained in H.R. 5376, Build Back Better Act.
H.R. 2255/S.1024, Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; policies contained in H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14.
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; and H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; policies contained in H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14.
Healthcare Workforce Resilience Act
Client: SOCIETY OF HOSPITAL MEDICINE · Firm: CHAMBER HILL STRATEGIES
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; H.R. 4521, America COMPETES Act of 2022; and policies contained in H.R. 5376, Build Back Better Act.
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; and H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; policies contained in H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14.
Issues generally related to the Orphan Drug Tax Credit, including provisions in H.R. 2623, Camerons Law and H.R. 5376, Build Back Better Act.
Elijah E. Cummings Lower Drug Costs Now Act
Client: BIOMARIN PHARMACEUTICAL INC. · Firm: CHAMBER HILL STRATEGIES
Issues generally related to biopharmaceutical drugs and drug development programs, including, but not limited to: Orphan Drug Act incentives, including H.R. 1629/S.250, the Fairness in Orphan Drug Exclusivity Act; drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021; access to rare disease and gene therapy drugs; FDA approvals of drugs designed to treat rare diseases, including gene therapies; and regulatory reforms generally, including but not limited to S. 3799, the PREVENT Pandemics Act, H.R. 6000, CURES 2.0, H.R. 6963, the Accelerated Approval Integrity Act of 2022, H.R. 6996, the Accelerating Access for Patients Act. Issues pertaining to newborn screening and gene panel screening, including provisions of H.R. 482/S.350 , the Newborn Screening Saves Lives Reauthorization Act of 2021. Policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021.
Elijah E. Cummings Lower Drug Costs Now Act
Client: BIOMARIN PHARMACEUTICAL INC. · Firm: CHAMBER HILL STRATEGIES
Issues generally related to biopharmaceutical drugs and drug development programs, including but not limited to drug pricing proposals, Medicaid payments, and access to rare disease and gene therapy drugs. Policies contained in drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021, and in H.R.3684 - Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act. Policies contained in 85 FR 87000, Medicaid Program; Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements.
Elijah E. Cummings Lower Drug Costs Now Act
Client: BIOMARIN PHARMACEUTICAL INC. · Firm: CHAMBER HILL STRATEGIES
Issues generally related to biopharmaceutical drugs and drug development programs, including, but not limited to: Orphan Drug Act incentives, including H.R. 1629/S.250, the Fairness in Orphan Drug Exclusivity Act; drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021; access to rare disease and gene therapy drugs; education and awareness of genetic rare bone disorders; FDA approvals of drugs designed to treat rare diseases, including gene therapies; and regulatory reforms generally, including but not limited to S. 3799, the PREVENT Pandemics Act, H.R. 6000, CURES 2.0, H.R. 6963, the Accelerated Approval Integrity Act of 2022, H.R. 6996, the Accelerating Access for Patients Act; H.R. 7667, Food and Drug Amendments of 2022, and S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act. Issues pertaining to newborn screening and gene panel screening, including provisions of H.R. 482/S.350 , the Newborn Screening Saves Lives Reauthorization Act of 2021. Policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021; P.L. 117-169, Inflation Reduction Act.
Elijah E. Cummings Lower Drug Costs Now Act
Client: BIOMARIN PHARMACEUTICAL INC. · Firm: CHAMBER HILL STRATEGIES
Issues generally related to biopharmaceutical drugs and drug development programs, including but not limited to drug pricing proposals, Medicaid payments, access to treatment through telehealth, and access to rare disease and gene therapy drugs. Policies contained in drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021, and in H.R.3684 - Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act. Policies contained in 85 FR 87000, Medicaid Program; Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements. H.R. 7489, Medicaid VBPs for Patients Act or the MVP Act.
Elijah E. Cummings Lower Drug Costs Now Act
Client: BIOMARIN PHARMACEUTICAL INC. · Firm: CHAMBER HILL STRATEGIES
Issues generally related to biopharmaceutical drugs and drug development programs, including, but not limited to: Orphan Drug Act incentives, including H.R. 1629/S.250, the Fairness in Orphan Drug Exclusivity Act; drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021; access to rare disease and gene therapy drugs; education and awareness of genetic rare bone disorders; FDA approvals of drugs designed to treat rare diseases, including gene therapies; and regulatory reforms generally, including but not limited to S. 3799, the PREVENT Pandemics Act, H.R. 6000, CURES 2.0, H.R. 6963, the Accelerated Approval Integrity Act of 2022, H.R. 6996, the Accelerating Access for Patients Act; H.R. 7667, Food and Drug Amendments of 2022, and S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act. Issues pertaining to newborn screening and gene panel screening, including provisions of H.R. 482/S.350 , the Newborn Screening Saves Lives Reauthorization Act of 2021. Policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021.
Elijah E. Cummings Lower Drug Costs Now Act
Client: BIOMARIN PHARMACEUTICAL INC. · Firm: CHAMBER HILL STRATEGIES
Issues generally related to biopharmaceutical drugs and drug development programs, including, but not limited to: Orphan Drug Act incentives, including H.R. 1629/S.250, the Fairness in Orphan Drug Exclusivity Act; drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021; access to rare disease and gene therapy drugs; education and awareness of genetic rare bone disorders; FDA approvals of drugs designed to treat rare diseases, including gene therapies; and regulatory reforms generally, including but not limited to S. 3799, the PREVENT Pandemics Act, H.R. 6000, CURES 2.0, H.R. 6963, the Accelerated Approval Integrity Act of 2022, H.R. 6996, the Accelerating Access for Patients Act; H.R. 7667, Food and Drug Amendments of 2022, and S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act. Issues pertaining to newborn screening and gene panel screening, including provisions of H.R. 482/S.350 , the Newborn Screening Saves Lives Reauthorization Act of 2021. Policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021; P.L. 117-169, Inflation Reduction Act.
Elijah E. Cummings Lower Drug Costs Now Act
Client: BIOMARIN PHARMACEUTICAL INC. · Firm: CHAMBER HILL STRATEGIES
Issues generally related to biopharmaceutical drugs and drug development programs, including but not limited to drug pricing proposals, Medicaid payments, access to treatment through telehealth, and access to rare disease and gene therapy drugs. Policies contained in drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021. Policies contained in 85 FR 87000, Medicaid Program; Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements. H.R. 7489, Medicaid VBPs for Patients Act or the MVP Act.
Elijah E. Cummings Lower Drug Costs Now Act
Client: BIOMARIN PHARMACEUTICAL INC. · Firm: CHAMBER HILL STRATEGIES
Issues generally related to biopharmaceutical drugs and drug development programs, including but not limited to drug pricing proposals, Medicaid payments, access to treatment through telehealth, and access to rare disease and gene therapy drugs. Policies contained in drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021. Policies contained in 85 FR 87000, Medicaid Program; Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements. H.R. 7489, Medicaid VBPs for Patients Act or the MVP Act.
Improving Seniors’ Timely Access to Care Act of 2021
Client: SOCIETY OF HOSPITAL MEDICINE · Firm: CHAMBER HILL STRATEGIES
H.R. 3650/S.2048, Improving Access to Medicare Coverage Act of 2021; H.R. 3173/S. 3018, Improving Seniors Timely Access to Care Act of 2021; H.R. 7053/S.3792, Hospital Inpatient Services Modernization Act; and H.R. 6020/S. 3314, Supporting Medicare Providers Act of 2021; policies related to physicians contained in H.R.3684, Infrastructure Investment and Jobs Act; H.R. 5376, Build Back Better Act; P.L. 117-328, Consolidated Appropriations Act, 2023 Issues pertaining to physician payment, quality measurement, observation care, prior authorization and access to care through Medicare Advantage, generally; and policies in the CY2022 Medicare Physician Payment Fee Schedule rule; and policies that would enhance reimbursement for services provided in response to a public health emergency involving infectious diseases.
Improving Seniors’ Timely Access to Care Act of 2021
Client: SOCIETY OF HOSPITAL MEDICINE · Firm: CHAMBER HILL STRATEGIES
H.R. 3650/S.2048, Improving Access to Medicare Coverage Act of 2021; H.R. 3173/S. 3018, Improving Seniors Timely Access to Care Act of 2021; H.R. 7053/S.3792, Hospital Inpatient Services Modernization Act; and H.R. 6020/S. 3314, Supporting Medicare Providers Act of 2021; policies related to physicians contained in H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act Issues pertaining to physician payment, quality measurement, observation care, prior authorization and access to care through Medicare Advantage, generally; and policies in the CY2022 Medicare Physician Payment Fee Schedule rule; and policies that would enhance reimbursement for services provided in response to a public health emergency involving infectious diseases.
Improving Seniors’ Timely Access to Care Act of 2021
Client: SOCIETY OF HOSPITAL MEDICINE · Firm: CHAMBER HILL STRATEGIES
H.R. 3650/S.2048, Improving Access to Medicare Coverage Act of 2021; H.R. 3173/S. 3018, Improving Seniors Timely Access to Care Act of 2021; H.R. 7053/S.3792, Hospital Inpatient Services Modernization Act; policies related to physician payments in P.L. 116-260, the Consolidated Appropriations Act, 2021, P.L. 117-7, to prevent across-the-board direct spending cuts, P.L. 117-71, Protecting Medicare and American Farmers from Sequester Cuts Act and H.R. 6020/S. 3314, Supporting Medicare Providers Act of 2021; policies related to physicians contained in H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act; and policies related to telehealth in P.L. 117-103, the Consolidated Appropriations Act, 2022. Issues pertaining to physician payment, quality measurement, observation care, prior authorization and access to care through Medicare Advantage, generally; and policies in the CY2022 Medicare Physician Payment Fee Schedule rule.
Improving Seniors’ Timely Access to Care Act of 2021
Client: SOCIETY OF HOSPITAL MEDICINE · Firm: CHAMBER HILL STRATEGIES
H.R. 3650/S.2048, Improving Access to Medicare Coverage Act of 2021; H.R. 3173/S. 3018, Improving Seniors Timely Access to Care Act of 2021; H.R. 7053/S.3792, Hospital Inpatient Services Modernization Act; policies related to physician payments in P.L. 116-260, the Consolidated Appropriations Act, 2021, P.L. 117-7, to prevent across-the-board direct spending cuts, P.L. 117-71, Protecting Medicare and American Farmers from Sequester Cuts Act and H.R. 6020/S. 3314, Supporting Medicare Providers Act of 2021; policies related to physicians contained in H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act; and policies related to telehealth in P.L. 117-103, the Consolidated Appropriations Act, 2022. Issues pertaining to physician payment, quality measurement, observation care, prior authorization and access to care through Medicare Advantage, generally; and policies in the CY2022 Medicare Physician Payment Fee Schedule rule.
Conrad State 30 and Physician Access Reauthorization Act
Client: SANFORD HEALTH · Firm: CHAMBER HILL STRATEGIES
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; and H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; policies contained in H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14.
Conrad State 30 and Physician Access Reauthorization Act
Client: SOCIETY OF HOSPITAL MEDICINE · Firm: CHAMBER HILL STRATEGIES
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; H.R. 4521, America COMPETES Act of 2022; and policies contained in H.R. 5376, Build Back Better Act.
Conrad State 30 and Physician Access Reauthorization Act
Client: SANFORD HEALTH · Firm: CHAMBER HILL STRATEGIES
H.R. 2255/S.1024, Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; policies contained in H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14.
Conrad State 30 and Physician Access Reauthorization Act
Client: SOCIETY OF HOSPITAL MEDICINE · Firm: CHAMBER HILL STRATEGIES
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; H.R. 4521, America COMPETES Act of 2022; and policies contained in H.R. 5376, Build Back Better Act.
Conrad State 30 and Physician Access Reauthorization Act
Client: SOCIETY OF HOSPITAL MEDICINE · Firm: CHAMBER HILL STRATEGIES
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; H.R. 4521, America COMPETES Act of 2022; and policies contained in H.R. 5376, Build Back Better Act.
Conrad State 30 and Physician Access Reauthorization Act
Client: SOCIETY OF HOSPITAL MEDICINE · Firm: CHAMBER HILL STRATEGIES
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; H.R. 4521, America COMPETES Act of 2022; and policies contained in H.R. 5376, Build Back Better Act.
Conrad State 30 and Physician Access Reauthorization Act
Client: SANFORD HEALTH · Firm: CHAMBER HILL STRATEGIES
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; and H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; policies contained in H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14.
Conrad State 30 and Physician Access Reauthorization Act
Client: SANFORD HEALTH · Firm: CHAMBER HILL STRATEGIES
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; and H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; policies contained in H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14.
H.R. 2255/S.1024, Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; policies contained in H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14.
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; H.R. 4521, America COMPETES Act of 2022; and policies contained in H.R. 5376, Build Back Better Act.
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; and H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; policies contained in H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14.
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; and H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; policies contained in H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14.
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; H.R. 4521, America COMPETES Act of 2022; and policies contained in H.R. 5376, Build Back Better Act.
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; and H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; policies contained in H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14.
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; H.R. 4521, America COMPETES Act of 2022; and policies contained in H.R. 5376, Build Back Better Act.
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; H.R. 4521, America COMPETES Act of 2022; and policies contained in H.R. 5376, Build Back Better Act.
Improving Access to Medicare Coverage Act of 2021
Client: SOCIETY OF HOSPITAL MEDICINE · Firm: CHAMBER HILL STRATEGIES
H.R. 3650/S.2048, Improving Access to Medicare Coverage Act of 2021; H.R. 3173/S. 3018, Improving Seniors Timely Access to Care Act of 2021; H.R. 7053/S.3792, Hospital Inpatient Services Modernization Act; policies related to physician payments in P.L. 116-260, the Consolidated Appropriations Act, 2021, P.L. 117-7, to prevent across-the-board direct spending cuts, P.L. 117-71, Protecting Medicare and American Farmers from Sequester Cuts Act and H.R. 6020/S. 3314, Supporting Medicare Providers Act of 2021; policies related to physicians contained in H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act; and policies related to telehealth in P.L. 117-103, the Consolidated Appropriations Act, 2022. Issues pertaining to physician payment, quality measurement, observation care, prior authorization and access to care through Medicare Advantage, generally; and policies in the CY2022 Medicare Physician Payment Fee Schedule rule.
Improving Access to Medicare Coverage Act of 2021
Client: SOCIETY OF HOSPITAL MEDICINE · Firm: CHAMBER HILL STRATEGIES
H.R. 3650/S.2048, Improving Access to Medicare Coverage Act of 2021; H.R. 3173/S. 3018, Improving Seniors Timely Access to Care Act of 2021; H.R. 7053/S.3792, Hospital Inpatient Services Modernization Act; and H.R. 6020/S. 3314, Supporting Medicare Providers Act of 2021; policies related to physicians contained in H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act Issues pertaining to physician payment, quality measurement, observation care, prior authorization and access to care through Medicare Advantage, generally; and policies in the CY2022 Medicare Physician Payment Fee Schedule rule; and policies that would enhance reimbursement for services provided in response to a public health emergency involving infectious diseases.
Improving Access to Medicare Coverage Act of 2021
Client: SOCIETY OF HOSPITAL MEDICINE · Firm: CHAMBER HILL STRATEGIES
H.R. 3650/S.2048, Improving Access to Medicare Coverage Act of 2021; H.R. 3173/S. 3018, Improving Seniors Timely Access to Care Act of 2021; H.R. 7053/S.3792, Hospital Inpatient Services Modernization Act; and H.R. 6020/S. 3314, Supporting Medicare Providers Act of 2021; policies related to physicians contained in H.R.3684, Infrastructure Investment and Jobs Act; H.R. 5376, Build Back Better Act; P.L. 117-328, Consolidated Appropriations Act, 2023 Issues pertaining to physician payment, quality measurement, observation care, prior authorization and access to care through Medicare Advantage, generally; and policies in the CY2022 Medicare Physician Payment Fee Schedule rule; and policies that would enhance reimbursement for services provided in response to a public health emergency involving infectious diseases.
Improving Access to Medicare Coverage Act of 2021
Client: SOCIETY OF HOSPITAL MEDICINE · Firm: CHAMBER HILL STRATEGIES
H.R. 3650/S.2048, Improving Access to Medicare Coverage Act of 2021; H.R. 3173/S. 3018, Improving Seniors Timely Access to Care Act of 2021; H.R. 7053/S.3792, Hospital Inpatient Services Modernization Act; policies related to physician payments in P.L. 116-260, the Consolidated Appropriations Act, 2021, P.L. 117-7, to prevent across-the-board direct spending cuts, P.L. 117-71, Protecting Medicare and American Farmers from Sequester Cuts Act and H.R. 6020/S. 3314, Supporting Medicare Providers Act of 2021; policies related to physicians contained in H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act; and policies related to telehealth in P.L. 117-103, the Consolidated Appropriations Act, 2022. Issues pertaining to physician payment, quality measurement, observation care, prior authorization and access to care through Medicare Advantage, generally; and policies in the CY2022 Medicare Physician Payment Fee Schedule rule.
Infrastructure Investment and Jobs Act
Client: LOGAN HEALTH (FORMALLY KNOWN AS KALISPELL REGIONAL HEALTHCARE) · Firm: CHAMBER HILL STRATEGIES
Policies that affect hospitals in P.L. 117-103, the Consolidated Appropriations Act, 2022, H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14.
Infrastructure Investment and Jobs Act
Client: SANFORD HEALTH · Firm: CHAMBER HILL STRATEGIES
Policies that affect hospitals and skilled nursing facilities in P.L. 117-103, the Consolidated Appropriations Act, 2022,, H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14; various value-based payment models at the Centers for Medicare and Medicaid Innovations.
Infrastructure Investment and Jobs Act
Client: HEALTH CARE SERVICE CORPORATION · Firm: CHAMBER HILL STRATEGIES
Issues related generally to: Medicare Advantage, Medicare Part D, and Medicaid managed care plans, including but not limited to policies related to social determinants of health, health equity, and maternal mortality, including policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021. Policies contained in P.L. 117-7, to prevent across-the-board direct spending cuts, and for other purposes, and P.L. 117-71, Protecting Medicare and American Farmers from Sequester Cuts Act. Policies contained in H.R.3684 - Infrastructure Investment and Jobs Act, and H.R. 5376, Build Back Better Act.
Infrastructure Investment and Jobs Act
Client: HEALTH CARE SERVICE CORPORATION · Firm: CHAMBER HILL STRATEGIES
Issues related generally to: Medicare Advantage, Medicare Part D, and Medicaid managed care plans, including but not limited to policies related to social determinants of health, health equity, and maternal mortality, including policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021. Policies contained in P.L. 117-7, to prevent across-the-board direct spending cuts, and for other purposes, and P.L. 117-71, Protecting Medicare and American Farmers from Sequester Cuts Act. Policies contained in H.R.3684 - Infrastructure Investment and Jobs Act, and H.R. 5376, Build Back Better Act.
Infrastructure Investment and Jobs Act
Client: SOCIETY OF HOSPITAL MEDICINE · Firm: CHAMBER HILL STRATEGIES
H.R. 3650/S.2048, Improving Access to Medicare Coverage Act of 2021; H.R. 3173/S. 3018, Improving Seniors Timely Access to Care Act of 2021; H.R. 7053/S.3792, Hospital Inpatient Services Modernization Act; and H.R. 6020/S. 3314, Supporting Medicare Providers Act of 2021; policies related to physicians contained in H.R.3684, Infrastructure Investment and Jobs Act; H.R. 5376, Build Back Better Act; P.L. 117-328, Consolidated Appropriations Act, 2023 Issues pertaining to physician payment, quality measurement, observation care, prior authorization and access to care through Medicare Advantage, generally; and policies in the CY2022 Medicare Physician Payment Fee Schedule rule; and policies that would enhance reimbursement for services provided in response to a public health emergency involving infectious diseases.
Infrastructure Investment and Jobs Act
Client: SANFORD HEALTH · Firm: CHAMBER HILL STRATEGIES
Policies that affect hospitals and skilled nursing facilities in P.L. 117-103, the Consolidated Appropriations Act, 2022,, H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14; various value-based payment models at the Centers for Medicare and Medicaid Innovation.
Infrastructure Investment and Jobs Act
Client: SOCIETY OF HOSPITAL MEDICINE · Firm: CHAMBER HILL STRATEGIES
H.R. 3650/S.2048, Improving Access to Medicare Coverage Act of 2021; H.R. 3173/S. 3018, Improving Seniors Timely Access to Care Act of 2021; H.R. 7053/S.3792, Hospital Inpatient Services Modernization Act; policies related to physician payments in P.L. 116-260, the Consolidated Appropriations Act, 2021, P.L. 117-7, to prevent across-the-board direct spending cuts, P.L. 117-71, Protecting Medicare and American Farmers from Sequester Cuts Act and H.R. 6020/S. 3314, Supporting Medicare Providers Act of 2021; policies related to physicians contained in H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act; and policies related to telehealth in P.L. 117-103, the Consolidated Appropriations Act, 2022. Issues pertaining to physician payment, quality measurement, observation care, prior authorization and access to care through Medicare Advantage, generally; and policies in the CY2022 Medicare Physician Payment Fee Schedule rule.
Infrastructure Investment and Jobs Act
Client: HEALTH CARE SERVICE CORPORATION · Firm: CHAMBER HILL STRATEGIES
Issues related generally to: the Affordable Care Act, insurance markets/stabilization, transparency, surprise billing, access to and payment for mental health care, and COVID-19 response, including those contained in but not limited to policies in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030, and P.L. 117-103, the Consolidated Appropriations Act, 2022; and health care policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021. Policies contained in H.R.3684 - Infrastructure Investment and Jobs Act, and H.R. 5376, Build Back Better Act.
Infrastructure Investment and Jobs Act
Client: SOCIETY OF HOSPITAL MEDICINE · Firm: CHAMBER HILL STRATEGIES
H.R. 3650/S.2048, Improving Access to Medicare Coverage Act of 2021; H.R. 3173/S. 3018, Improving Seniors Timely Access to Care Act of 2021; H.R. 7053/S.3792, Hospital Inpatient Services Modernization Act; policies related to physician payments in P.L. 116-260, the Consolidated Appropriations Act, 2021, P.L. 117-7, to prevent across-the-board direct spending cuts, P.L. 117-71, Protecting Medicare and American Farmers from Sequester Cuts Act and H.R. 6020/S. 3314, Supporting Medicare Providers Act of 2021; policies related to physicians contained in H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act; and policies related to telehealth in P.L. 117-103, the Consolidated Appropriations Act, 2022. Issues pertaining to physician payment, quality measurement, observation care, prior authorization and access to care through Medicare Advantage, generally; and policies in the CY2022 Medicare Physician Payment Fee Schedule rule.
Infrastructure Investment and Jobs Act
Client: HEALTH CARE SERVICE CORPORATION · Firm: CHAMBER HILL STRATEGIES
Issues related generally to: the Affordable Care Act, insurance markets/stabilization, transparency, surprise billing, access to and payment for mental health care, and COVID-19 response, including those contained in but not limited to policies in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030, and P.L. 117-103, the Consolidated Appropriations Act, 2022; and health care policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021. Policies contained in H.R.3684 - Infrastructure Investment and Jobs Act, H.R. 5376, Build Back Better Act; H.R. 7666, Restoring Hope for Mental Health and Well Being Act of 2022; and H.R. 5218, Collaborate in an Orderly and Cohesive Manner Act.
Infrastructure Investment and Jobs Act
Client: BIOMARIN PHARMACEUTICAL INC. · Firm: CHAMBER HILL STRATEGIES
Issues generally related to biopharmaceutical drugs and drug development programs, including but not limited to drug pricing proposals, Medicaid payments, and access to rare disease and gene therapy drugs. Policies contained in drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021, and in H.R.3684 - Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act. Policies contained in 85 FR 87000, Medicaid Program; Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements.
Infrastructure Investment and Jobs Act
Client: SOCIETY OF HOSPITAL MEDICINE · Firm: CHAMBER HILL STRATEGIES
H.R. 3650/S.2048, Improving Access to Medicare Coverage Act of 2021; H.R. 3173/S. 3018, Improving Seniors Timely Access to Care Act of 2021; H.R. 7053/S.3792, Hospital Inpatient Services Modernization Act; and H.R. 6020/S. 3314, Supporting Medicare Providers Act of 2021; policies related to physicians contained in H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act Issues pertaining to physician payment, quality measurement, observation care, prior authorization and access to care through Medicare Advantage, generally; and policies in the CY2022 Medicare Physician Payment Fee Schedule rule; and policies that would enhance reimbursement for services provided in response to a public health emergency involving infectious diseases.
Infrastructure Investment and Jobs Act
Client: BIOMARIN PHARMACEUTICAL INC. · Firm: CHAMBER HILL STRATEGIES
Policies contained in H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act.
Infrastructure Investment and Jobs Act
Client: NATIONAL PARTNERSHIP FOR WOMEN AND FAMILIES · Firm: CHAMBER HILL STRATEGIES
General education around paid family, medical and sick leave issues; paid sick day policies in P.L. 117-2, the Consolidated Appropriations Act, 2021, H.R. 804/S. 248, the FAMILY Act; policies contained in H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act.
Infrastructure Investment and Jobs Act
Client: LOGAN HEALTH (FORMALLY KNOWN AS KALISPELL REGIONAL HEALTHCARE) · Firm: CHAMBER HILL STRATEGIES
Policies that affect hospitals in P.L. 117-103, the Consolidated Appropriations Act, 2022, H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14.
Infrastructure Investment and Jobs Act
Client: BIOMARIN PHARMACEUTICAL INC. · Firm: CHAMBER HILL STRATEGIES
Policies contained in H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act.
Infrastructure Investment and Jobs Act
Client: BIOMARIN PHARMACEUTICAL INC. · Firm: CHAMBER HILL STRATEGIES
Policies contained in H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act; P.L. 117-328, Consolidated Appropriations Act, 2023
Infrastructure Investment and Jobs Act
Client: BIOMARIN PHARMACEUTICAL INC. · Firm: CHAMBER HILL STRATEGIES
Policies contained in H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act.
Infrastructure Investment and Jobs Act
Client: BIOMARIN PHARMACEUTICAL INC. · Firm: CHAMBER HILL STRATEGIES
Issues generally related to biopharmaceutical drugs and drug development programs, including but not limited to drug pricing proposals, Medicaid payments, access to treatment through telehealth, and access to rare disease and gene therapy drugs. Policies contained in drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021, and in H.R.3684 - Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act. Policies contained in 85 FR 87000, Medicaid Program; Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements. H.R. 7489, Medicaid VBPs for Patients Act or the MVP Act.
United States Innovation and Competition Act of 2021
Client: SOCIETY OF HOSPITAL MEDICINE · Firm: CHAMBER HILL STRATEGIES
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; H.R. 4521, America COMPETES Act of 2022; and policies contained in H.R. 5376, Build Back Better Act.
United States Innovation and Competition Act of 2021
Client: SOCIETY OF HOSPITAL MEDICINE · Firm: CHAMBER HILL STRATEGIES
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; H.R. 4521, America COMPETES Act of 2022; and policies contained in H.R. 5376, Build Back Better Act.
United States Innovation and Competition Act of 2021
Client: SOCIETY OF HOSPITAL MEDICINE · Firm: CHAMBER HILL STRATEGIES
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; H.R. 4521, America COMPETES Act of 2022; and policies contained in H.R. 5376, Build Back Better Act.
United States Innovation and Competition Act of 2021
Client: SOCIETY OF HOSPITAL MEDICINE · Firm: CHAMBER HILL STRATEGIES
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; H.R. 4521, America COMPETES Act of 2022; and policies contained in H.R. 5376, Build Back Better Act.
Newborn Screening Saves Lives Reauthorization Act of 2021
Client: BIOMARIN PHARMACEUTICAL INC. · Firm: CHAMBER HILL STRATEGIES
Issues generally related to biopharmaceutical drugs and drug development programs, including, but not limited to: Orphan Drug Act incentives, including H.R. 1629/S.250, the Fairness in Orphan Drug Exclusivity Act; drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021; access to rare disease and gene therapy drugs; education and awareness of genetic rare bone disorders; FDA approvals of drugs designed to treat rare diseases, including gene therapies; and regulatory reforms generally, including but not limited to S. 3799, the PREVENT Pandemics Act, H.R. 6000, CURES 2.0, H.R. 6963, the Accelerated Approval Integrity Act of 2022, H.R. 6996, the Accelerating Access for Patients Act; H.R. 7667, Food and Drug Amendments of 2022, and S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act. Issues pertaining to newborn screening and gene panel screening, including provisions of H.R. 482/S.350 , the Newborn Screening Saves Lives Reauthorization Act of 2021. Policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021; P.L. 117-169, Inflation Reduction Act.
Newborn Screening Saves Lives Reauthorization Act of 2021
Client: BIOMARIN PHARMACEUTICAL INC. · Firm: CHAMBER HILL STRATEGIES
Issues generally related to biopharmaceutical drugs and drug development programs, including, but not limited to: Orphan Drug Act incentives, including H.R. 1629/S.250, the Fairness in Orphan Drug Exclusivity Act; drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021; access to rare disease and gene therapy drugs; education and awareness of genetic rare bone disorders; FDA approvals of drugs designed to treat rare diseases, including gene therapies; and regulatory reforms generally, including but not limited to S. 3799, the PREVENT Pandemics Act, H.R. 6000, CURES 2.0, H.R. 6963, the Accelerated Approval Integrity Act of 2022, H.R. 6996, the Accelerating Access for Patients Act; H.R. 7667, Food and Drug Amendments of 2022, and S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act. Issues pertaining to newborn screening and gene panel screening, including provisions of H.R. 482/S.350 , the Newborn Screening Saves Lives Reauthorization Act of 2021. Policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021; P.L. 117-169, Inflation Reduction Act.
Newborn Screening Saves Lives Reauthorization Act of 2021
Client: BIOMARIN PHARMACEUTICAL INC. · Firm: CHAMBER HILL STRATEGIES
Issues generally related to biopharmaceutical drugs and drug development programs, including, but not limited to: Orphan Drug Act incentives, including H.R. 1629/S.250, the Fairness in Orphan Drug Exclusivity Act; drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021; access to rare disease and gene therapy drugs; education and awareness of genetic rare bone disorders; FDA approvals of drugs designed to treat rare diseases, including gene therapies; and regulatory reforms generally, including but not limited to S. 3799, the PREVENT Pandemics Act, H.R. 6000, CURES 2.0, H.R. 6963, the Accelerated Approval Integrity Act of 2022, H.R. 6996, the Accelerating Access for Patients Act; H.R. 7667, Food and Drug Amendments of 2022, and S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act. Issues pertaining to newborn screening and gene panel screening, including provisions of H.R. 482/S.350 , the Newborn Screening Saves Lives Reauthorization Act of 2021. Policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021.
Newborn Screening Saves Lives Reauthorization Act of 2021
Client: BIOMARIN PHARMACEUTICAL INC. · Firm: CHAMBER HILL STRATEGIES
Issues generally related to biopharmaceutical drugs and drug development programs, including, but not limited to: Orphan Drug Act incentives, including H.R. 1629/S.250, the Fairness in Orphan Drug Exclusivity Act; drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021; access to rare disease and gene therapy drugs; FDA approvals of drugs designed to treat rare diseases, including gene therapies; and regulatory reforms generally, including but not limited to S. 3799, the PREVENT Pandemics Act, H.R. 6000, CURES 2.0, H.R. 6963, the Accelerated Approval Integrity Act of 2022, H.R. 6996, the Accelerating Access for Patients Act. Issues pertaining to newborn screening and gene panel screening, including provisions of H.R. 482/S.350 , the Newborn Screening Saves Lives Reauthorization Act of 2021. Policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021.
Collaborate in an Orderly and Cohesive Manner Act
Client: HEALTH CARE SERVICE CORPORATION · Firm: CHAMBER HILL STRATEGIES
Issues generally in the Affordable Care Act; issues related to insurance markets and stabilization, transparency, surprise billing, access to and payment for mental health care, and COVID-19 response in P.L. 117-103, the Consolidated Appropriations Act, 2022; H.R. 7666, Restoring Hope for Mental Health and Well-Being Act of 2022; and health care policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021; P.L. 117-169, Inflation Reduction Act of 2021; H.R. 5218, Collaborate in an Orderly and Cohesive Manner Act.
Collaborate in an Orderly and Cohesive Manner Act
Client: HEALTH CARE SERVICE CORPORATION · Firm: CHAMBER HILL STRATEGIES
Issues generally in the Affordable Care Act; issues related to insurance markets and stabilization, transparency, surprise billing, access to and payment for mental health care, and COVID-19 response in P.L. 117-103, the Consolidated Appropriations Act, 2022; H.R. 7666, Restoring Hope for Mental Health and Well-Being Act of 2022; and health care policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021; P.L. 117-169, Inflation Reduction Act of 2021; H.R. 5218, Collaborate in an Orderly and Cohesive Manner Act.
Collaborate in an Orderly and Cohesive Manner Act
Client: HEALTH CARE SERVICE CORPORATION · Firm: CHAMBER HILL STRATEGIES
Issues related generally to: the Affordable Care Act, insurance markets/stabilization, transparency, surprise billing, access to and payment for mental health care, and COVID-19 response, including those contained in but not limited to policies in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030, and P.L. 117-103, the Consolidated Appropriations Act, 2022; and health care policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021. Policies contained in H.R.3684 - Infrastructure Investment and Jobs Act, H.R. 5376, Build Back Better Act; H.R. 7666, Restoring Hope for Mental Health and Well Being Act of 2022; and H.R. 5218, Collaborate in an Orderly and Cohesive Manner Act.
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; and H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; policies contained in H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14.
Inflation Reduction Act of 2022
Client: BIOMARIN PHARMACEUTICAL INC. · Firm: CHAMBER HILL STRATEGIES
Issues generally related to biopharmaceutical drugs and drug development programs, including but not limited to drug pricing proposals, Medicaid payments, access to treatment through telehealth, and access to rare disease and gene therapy drugs. Policies contained in drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021, and in H.R.3684 - Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act. Policies contained in 85 FR 87000, Medicaid Program; Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements. H.R. 7489, Medicaid VBPs for Patients Act or the MVP Act.
Inflation Reduction Act of 2022
Client: HEALTH CARE SERVICE CORPORATION · Firm: CHAMBER HILL STRATEGIES
Issues related generally to: Medicare Advantage, Medicare Part D, and Medicaid managed care plans, including but not limited to policies related to social determinants of health, health equity, and maternal mortality, including policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021. Policies contained in P.L. 117-7, to prevent across-the-board direct spending cuts, and for other purposes, and P.L. 117-71, Protecting Medicare and American Farmers from Sequester Cuts Act. Policies contained in H.R.3684 - Infrastructure Investment and Jobs Act, and H.R. 5376, Build Back Better Act.
Inflation Reduction Act of 2022
Client: SOCIETY OF HOSPITAL MEDICINE · Firm: CHAMBER HILL STRATEGIES
H.R. 3650/S.2048, Improving Access to Medicare Coverage Act of 2021; H.R. 3173/S. 3018, Improving Seniors Timely Access to Care Act of 2021; H.R. 7053/S.3792, Hospital Inpatient Services Modernization Act; and H.R. 6020/S. 3314, Supporting Medicare Providers Act of 2021; policies related to physicians contained in H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act Issues pertaining to physician payment, quality measurement, observation care, prior authorization and access to care through Medicare Advantage, generally; and policies in the CY2022 Medicare Physician Payment Fee Schedule rule; and policies that would enhance reimbursement for services provided in response to a public health emergency involving infectious diseases.
Inflation Reduction Act of 2022
Client: LOGAN HEALTH (FORMALLY KNOWN AS KALISPELL REGIONAL HEALTHCARE) · Firm: CHAMBER HILL STRATEGIES
Policies that affect hospitals in P.L. 117-103, the Consolidated Appropriations Act, 2022, H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14.
Inflation Reduction Act of 2022
Client: LOGAN HEALTH (FORMALLY KNOWN AS KALISPELL REGIONAL HEALTHCARE) · Firm: CHAMBER HILL STRATEGIES
Policies that affect hospitals in P.L. 117-103, the Consolidated Appropriations Act, 2022, H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14.
Inflation Reduction Act of 2022
Client: BIOMARIN PHARMACEUTICAL INC. · Firm: CHAMBER HILL STRATEGIES
Policies contained in H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act.
Inflation Reduction Act of 2022
Client: SOCIETY OF HOSPITAL MEDICINE · Firm: CHAMBER HILL STRATEGIES
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; H.R. 4521, America COMPETES Act of 2022; and policies contained in H.R. 5376, Build Back Better Act.
Inflation Reduction Act of 2022
Client: NATIONAL ACADEMY OF ELDER LAW ATTORNEYS, INC. · Firm: CHAMBER HILL STRATEGIES
General education around long term services and supports, home and community-based services issues, spousal impoverishment, Medicaid eligibility in Section 1115 waivers, Money Follows the Person program; home and community services policies in H.R. 5376, Build Back Better Act.
Policies that affect hospitals and skilled nursing facilities in P.L. 117-103, the Consolidated Appropriations Act, 2022,, H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14; various value-based payment models at the Centers for Medicare and Medicaid Innovation.
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; and H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; policies contained in H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14.
Inflation Reduction Act of 2022
Client: NATIONAL ACADEMY OF ELDER LAW ATTORNEYS, INC. · Firm: CHAMBER HILL STRATEGIES
General education around long term services and supports, home and community-based services issues, spousal impoverishment, Medicaid eligibility in Section 1115 waivers, Money Follows the Person program; home and community services policies in H.R. 5376, Build Back Better Act.
Policies that affect hospitals and skilled nursing facilities in P.L. 117-103, the Consolidated Appropriations Act, 2022,, H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14; various value-based payment models at the Centers for Medicare and Medicaid Innovations.
Inflation Reduction Act of 2022
Client: BIOMARIN PHARMACEUTICAL INC. · Firm: CHAMBER HILL STRATEGIES
Issues generally related to the Orphan Drug Tax Credit, including provisions in H.R. 2623, Camerons Law and H.R. 5376, Build Back Better Act.
Inflation Reduction Act of 2022
Client: SOCIETY OF HOSPITAL MEDICINE · Firm: CHAMBER HILL STRATEGIES
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; H.R. 4521, America COMPETES Act of 2022; and policies contained in H.R. 5376, Build Back Better Act.
Inflation Reduction Act of 2022
Client: SOCIETY OF HOSPITAL MEDICINE · Firm: CHAMBER HILL STRATEGIES
H.R. 3650/S.2048, Improving Access to Medicare Coverage Act of 2021; H.R. 3173/S. 3018, Improving Seniors Timely Access to Care Act of 2021; H.R. 7053/S.3792, Hospital Inpatient Services Modernization Act; policies related to physician payments in P.L. 116-260, the Consolidated Appropriations Act, 2021, P.L. 117-7, to prevent across-the-board direct spending cuts, P.L. 117-71, Protecting Medicare and American Farmers from Sequester Cuts Act and H.R. 6020/S. 3314, Supporting Medicare Providers Act of 2021; policies related to physicians contained in H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act; and policies related to telehealth in P.L. 117-103, the Consolidated Appropriations Act, 2022. Issues pertaining to physician payment, quality measurement, observation care, prior authorization and access to care through Medicare Advantage, generally; and policies in the CY2022 Medicare Physician Payment Fee Schedule rule.
2023 · second_quarter · Q2
Issues pertaining to physician payment, quality measurement, observation care, prior authorization and access to care through Medicare Advantage
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANFORD HEALTH via CHAMBER HILL STRATEGIES
2023 · second_quarter · Q2
Policies that affect hospitals, skilled nursing facilities, and health systems
Policies impacting access to pharmacogenomic testing
Policies affecting employment-based immigration for physicians
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICAID HEALTH PLANS OF AMERICA via CHAMBER HILL STRATEGIES
2023 · first_quarter · Q1
Policies impacting Medicaid managed care organizations; policies related to individuals dually eligible for Medicare and Medicaid; policies affecting health care workforce
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LOGAN HEALTH (FORMALLY KNOWN AS KALISPELL REGIONAL HEALTHCARE) via CHAMBER HILL STRATEGIES
2023 · first_quarter · Q1
Policies impacting hospitals and health systems
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN BURN ASSOCIATION via CHAMBER HILL STRATEGIES
2023 · first_quarter · Q1
Funding for the Military Burn Research Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOCIETY OF HOSPITAL MEDICINE via CHAMBER HILL STRATEGIES
2023 · first_quarter · Q1
Policies related to employment-based immigration for physicians
Issues pertaining to physician payment, quality measurement, observation care, prior authorization and access to care through Medicare Advantage
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANFORD HEALTH via CHAMBER HILL STRATEGIES
2023 · first_quarter · Q1
Policies impacting access to pharmacogenomic testing
Policies affecting employment-based immigration for physicians
Policies that affect hospitals, skilled nursing facilities, and health systems
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CIC HEALTH via CHAMBER HILL STRATEGIES
2023 · first_quarter · Q1
Policies to support public health access and pandemic preparedness; draft proposals related to the PREVENT Pandemics Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICAID HEALTH PLANS OF AMERICA via CHAMBER HILL STRATEGIES
2022 · fourth_quarter · 4A
Medicaid policies in P.L. 117-328, Consolidated Appropriations Act, 2023; issues pertaining to care for individuals dually eligible for Medicaid and Medicare services
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CIC HEALTH via CHAMBER HILL STRATEGIES
2022 · fourth_quarter · 4A
Policies to support public health access and pandemic preparedness; S.3799, the PREVENT Pandemics Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOCIETY OF HOSPITAL MEDICINE via CHAMBER HILL STRATEGIES
2022 · fourth_quarter · Q4
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; H.R. 4521, America COMPETES Act of 2022; and policies contained in H.R. 5376, Build Back Better Act.
H.R. 1384/S. 445, the Mainstreaming Addiction Treatment Act of 2019; H.R. 7666, Restoring Hope for Mental Health and Well Being Act of 2022; issues generally pertaining to the impact of COVID-19 on hospitalists.
H.R. 3650/S.2048, Improving Access to Medicare Coverage Act of 2021; H.R. 3173/S. 3018, Improving Seniors Timely Access to Care Act of 2021; H.R. 7053/S.3792, Hospital Inpatient Services Modernization Act; and H.R. 6020/S. 3314, Supporting Medicare Providers Act of 2021; policies related to physicians contained in H.R.3684, Infrastructure Investment and Jobs Act; H.R. 5376, Build Back Better Act; P.L. 117-328, Consolidated Appropriations Act, 2023 Issues pertaining to physician payment, quality measurement, observation care, prior authorization and access to care through Medicare Advantage, generally; and policies in the CY2022 Medicare Physician Payment Fee Schedule rule; and policies that would enhance reimbursement for services provided in response to a public health emergency involving infectious diseases.
SANFORD HEALTH via CHAMBER HILL STRATEGIES
2022 · fourth_quarter · Q4
H.R. 6000, Cures 2.0 Act
Policies that affect hospitals and skilled nursing facilities in P.L. 117-103, the Consolidated Appropriations Act, 2022; P.L. 117-169, Inflation Reduction Act; P.L. 117-328, Consolidated Appropriations Act, 2023
H.R. 2255/S.1024, Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; policies contained in H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14.
LOGAN HEALTH (FORMALLY KNOWN AS KALISPELL REGIONAL HEALTHCARE) via CHAMBER HILL STRATEGIES
2022 · fourth_quarter · Q4
Policies that affect hospitals in P.L. 117-103, the Consolidated Appropriations Act, 2022 and P.L. 117-169, Inflation Reduction Act; P.L. 117-328, Consolidated Appropriations Act, 2023
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTH CARE SERVICE CORPORATION via CHAMBER HILL STRATEGIES
2022 · fourth_quarter · 4T
Issues related generally to: Medicare Advantage, Medicare Part D, and Medicaid managed care plans, including but not limited to policies related to social determinants of health, health equity, and maternal mortality, including policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021.
Issues generally in the Affordable Care Act; issues related to insurance markets and stabilization, transparency, surprise billing, access to and payment for mental health care, and COVID-19 response in P.L. 117-103, the Consolidated Appropriations Act, 2022; H.R. 7666, Restoring Hope for Mental Health and Well-Being Act of 2022; and health care policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021; P.L. 117-169, Inflation Reduction Act of 2021; H.R. 5218, Collaborate in an Orderly and Cohesive Manner Act.
BIOMARIN PHARMACEUTICAL INC. via CHAMBER HILL STRATEGIES
2022 · fourth_quarter · 4T
Issues generally related to the Orphan Drug Tax Credit, including provisions in H.R. 2623, Camerons Law and H.R. 5376, Build Back Better Act.
Policies contained in H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act; P.L. 117-328, Consolidated Appropriations Act, 2023
Issues generally related to biopharmaceutical drugs and drug development programs, including but not limited to drug pricing proposals, Medicaid payments, access to treatment through telehealth, and access to rare disease and gene therapy drugs. Policies contained in drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021. Policies contained in 85 FR 87000, Medicaid Program; Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements. H.R. 7489, Medicaid VBPs for Patients Act or the MVP Act.
AMERICAN BURN ASSOCIATION via CHAMBER HILL STRATEGIES
2022 · fourth_quarter · Q4
Patient safety policies related to home oxygen therapy.
Funding for the Military Burn Research Program in Senate proposals to fund the Department of Defense for FY2023; H.R.8236, Department of Defense Appropriations Act, 2023; P.L. 117-328, Consolidated Appropriations Act, 2023
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CIC HEALTH via CHAMBER HILL STRATEGIES
2022 · fourth_quarter · RR
Policies to support public health access and pandemic preparedness
MEDICAID HEALTH PLANS OF AMERICA via CHAMBER HILL STRATEGIES
2022 · fourth_quarter · RR
Medicaid coverage, Policies related to the Public Health Emergency
Medicaid coverage, Policies related to the Public Health Emergency
SOCIETY OF HOSPITAL MEDICINE via CHAMBER HILL STRATEGIES
2022 · third_quarter · Q3
H.R. 3650/S.2048, Improving Access to Medicare Coverage Act of 2021; H.R. 3173/S. 3018, Improving Seniors Timely Access to Care Act of 2021; H.R. 7053/S.3792, Hospital Inpatient Services Modernization Act; and H.R. 6020/S. 3314, Supporting Medicare Providers Act of 2021; policies related to physicians contained in H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act Issues pertaining to physician payment, quality measurement, observation care, prior authorization and access to care through Medicare Advantage, generally; and policies in the CY2022 Medicare Physician Payment Fee Schedule rule; and policies that would enhance reimbursement for services provided in response to a public health emergency involving infectious diseases.
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; H.R. 4521, America COMPETES Act of 2022; and policies contained in H.R. 5376, Build Back Better Act.
BIOMARIN PHARMACEUTICAL INC. via CHAMBER HILL STRATEGIES
2022 · third_quarter · Q3
H.R. 785/S.2313, a bill for the relief of Maria Isabel Bueso Barrera, Alberto Bueso Mendoza, and Karla Maria Barrera De Bueso.
Issues generally related to biopharmaceutical drugs and drug development programs, including, but not limited to: Orphan Drug Act incentives, including H.R. 1629/S.250, the Fairness in Orphan Drug Exclusivity Act; drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021; access to rare disease and gene therapy drugs; education and awareness of genetic rare bone disorders; FDA approvals of drugs designed to treat rare diseases, including gene therapies; and regulatory reforms generally, including but not limited to S. 3799, the PREVENT Pandemics Act, H.R. 6000, CURES 2.0, H.R. 6963, the Accelerated Approval Integrity Act of 2022, H.R. 6996, the Accelerating Access for Patients Act; H.R. 7667, Food and Drug Amendments of 2022, and S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act. Issues pertaining to newborn screening and gene panel screening, including provisions of H.R. 482/S.350 , the Newborn Screening Saves Lives Reauthorization Act of 2021. Policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021; P.L. 117-169, Inflation Reduction Act.
AMERICAN BURN ASSOCIATION via CHAMBER HILL STRATEGIES
2022 · third_quarter · Q3
Patient safety policies related to home oxygen therapy.
Funding for the Military Burn Research Program in Senate proposals to fund the Department of Defense for FY2023, H.R.8236, Department of Defense Appropriations Act, 2023
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LOGAN HEALTH (FORMALLY KNOWN AS KALISPELL REGIONAL HEALTHCARE) via CHAMBER HILL STRATEGIES
2022 · third_quarter · Q3
Policies that affect hospitals in P.L. 117-103, the Consolidated Appropriations Act, 2022 and P.L. 117-169, Inflation Reduction Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANFORD HEALTH via CHAMBER HILL STRATEGIES
2022 · third_quarter · Q3
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; and H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; policies contained in H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14.
H.R. 6000, Cures 2.0 Act
Policies that affect hospitals and skilled nursing facilities in P.L. 117-103, the Consolidated Appropriations Act, 2022 and P.L. 117-169, Inflation Reduction Act
NATIONAL ACADEMY OF ELDER LAW ATTORNEYS, INC. via CHAMBER HILL STRATEGIES
2022 · third_quarter · 3T
General education around long term services and supports, home and community-based services issues, spousal impoverishment, Medicaid eligibility in Section 1115 waivers, Money Follows the Person program; home and community services policies in H.R. 5376, Build Back Better Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTH CARE SERVICE CORPORATION via CHAMBER HILL STRATEGIES
2022 · third_quarter · Q3
Issues related generally to: Medicare Advantage, Medicare Part D, and Medicaid managed care plans, including but not limited to policies related to social determinants of health, health equity, and maternal mortality, including policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021.
Issues generally in the Affordable Care Act; issues related to insurance markets and stabilization, transparency, surprise billing, access to and payment for mental health care, and COVID-19 response in P.L. 117-103, the Consolidated Appropriations Act, 2022; H.R. 7666, Restoring Hope for Mental Health and Well-Being Act of 2022; and health care policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021; P.L. 117-169, Inflation Reduction Act of 2021; H.R. 5218, Collaborate in an Orderly and Cohesive Manner Act.
HEALTH CARE SERVICE CORPORATION via CHAMBER HILL STRATEGIES
2022 · second_quarter · Q2
Issues related generally to: Medicare Advantage, Medicare Part D, and Medicaid managed care plans, including but not limited to policies related to social determinants of health, health equity, and maternal mortality, including policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021. Policies contained in P.L. 117-7, to prevent across-the-board direct spending cuts, and for other purposes, and P.L. 117-71, Protecting Medicare and American Farmers from Sequester Cuts Act. Policies contained in H.R.3684 - Infrastructure Investment and Jobs Act, and H.R. 5376, Build Back Better Act.
Issues related generally to: the Affordable Care Act, insurance markets/stabilization, transparency, surprise billing, access to and payment for mental health care, and COVID-19 response, including those contained in but not limited to policies in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030, and P.L. 117-103, the Consolidated Appropriations Act, 2022; and health care policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021. Policies contained in H.R.3684 - Infrastructure Investment and Jobs Act, H.R. 5376, Build Back Better Act; H.R. 7666, Restoring Hope for Mental Health and Well Being Act of 2022; and H.R. 5218, Collaborate in an Orderly and Cohesive Manner Act.
BIOMARIN PHARMACEUTICAL INC. via CHAMBER HILL STRATEGIES
2022 · second_quarter · Q2
Issues generally related to biopharmaceutical drugs and drug development programs, including but not limited to drug pricing proposals, Medicaid payments, access to treatment through telehealth, and access to rare disease and gene therapy drugs. Policies contained in drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021, and in H.R.3684 - Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act. Policies contained in 85 FR 87000, Medicaid Program; Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements. H.R. 7489, Medicaid VBPs for Patients Act or the MVP Act.
Issues generally related to biopharmaceutical drugs and drug development programs, including, but not limited to: Orphan Drug Act incentives, including H.R. 1629/S.250, the Fairness in Orphan Drug Exclusivity Act; drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021; access to rare disease and gene therapy drugs; education and awareness of genetic rare bone disorders; FDA approvals of drugs designed to treat rare diseases, including gene therapies; and regulatory reforms generally, including but not limited to S. 3799, the PREVENT Pandemics Act, H.R. 6000, CURES 2.0, H.R. 6963, the Accelerated Approval Integrity Act of 2022, H.R. 6996, the Accelerating Access for Patients Act; H.R. 7667, Food and Drug Amendments of 2022, and S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act. Issues pertaining to newborn screening and gene panel screening, including provisions of H.R. 482/S.350 , the Newborn Screening Saves Lives Reauthorization Act of 2021. Policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021.
AMERICAN BURN ASSOCIATION via CHAMBER HILL STRATEGIES
2022 · second_quarter · Q2
Patient safety policies related to home oxygen therapy.
Funding for the Military Burn Research Program in Senate proposals to fund the Department of Defense for FY2023, H.R.8236, Department of Defense Appropriations Act, 2023
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LOGAN HEALTH (FORMALLY KNOWN AS KALISPELL REGIONAL HEALTHCARE) via CHAMBER HILL STRATEGIES
2022 · second_quarter · Q2
Policies that affect hospitals in P.L. 117-103, the Consolidated Appropriations Act, 2022, H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ACADEMY OF ELDER LAW ATTORNEYS, INC. via CHAMBER HILL STRATEGIES
2022 · second_quarter · Q2
General education around long term services and supports, home and community-based services issues, spousal impoverishment, Medicaid eligibility in Section 1115 waivers, Money Follows the Person program; home and community services policies in H.R. 5376, Build Back Better Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOCIETY OF HOSPITAL MEDICINE via CHAMBER HILL STRATEGIES
2022 · second_quarter · Q2
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; H.R. 4521, America COMPETES Act of 2022; and policies contained in H.R. 5376, Build Back Better Act.
H.R. 3650/S.2048, Improving Access to Medicare Coverage Act of 2021; H.R. 3173/S. 3018, Improving Seniors Timely Access to Care Act of 2021; H.R. 7053/S.3792, Hospital Inpatient Services Modernization Act; policies related to physician payments in P.L. 116-260, the Consolidated Appropriations Act, 2021, P.L. 117-7, to prevent across-the-board direct spending cuts, P.L. 117-71, Protecting Medicare and American Farmers from Sequester Cuts Act and H.R. 6020/S. 3314, Supporting Medicare Providers Act of 2021; policies related to physicians contained in H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act; and policies related to telehealth in P.L. 117-103, the Consolidated Appropriations Act, 2022. Issues pertaining to physician payment, quality measurement, observation care, prior authorization and access to care through Medicare Advantage, generally; and policies in the CY2022 Medicare Physician Payment Fee Schedule rule.
SANFORD HEALTH via CHAMBER HILL STRATEGIES
2022 · second_quarter · Q2
Policies that affect hospitals and skilled nursing facilities in P.L. 117-103, the Consolidated Appropriations Act, 2022,, H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14; various value-based payment models at the Centers for Medicare and Medicaid Innovation.
H.R. 6000, Cures 2.0 Act.
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; and H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; policies contained in H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14.
NATIONAL PARTNERSHIP FOR WOMEN AND FAMILIES via CHAMBER HILL STRATEGIES
2022 · first_quarter · 1T
General education around paid family, medical and sick leave issues; paid sick day policies in P.L. 117-2, the Consolidated Appropriations Act, 2021, H.R. 804/S. 248, the FAMILY Act; policies contained in H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LOGAN HEALTH (FORMALLY KNOWN AS KALISPELL REGIONAL HEALTHCARE) via CHAMBER HILL STRATEGIES
2022 · first_quarter · Q1
Policies that affect hospitals in P.L. 117-103, the Consolidated Appropriations Act, 2022, H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN BURN ASSOCIATION via CHAMBER HILL STRATEGIES
2022 · first_quarter · Q1
Funding for the Military Burn Research Program in P.L. 117-103, the Consolidated Appropriations Act, 2022.
Patient safety policies related to home oxygen therapy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOMARIN PHARMACEUTICAL INC. via CHAMBER HILL STRATEGIES
2022 · first_quarter · Q1
Policies contained in H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act.
Issues generally related to biopharmaceutical drugs and drug development programs, including but not limited to drug pricing proposals, Medicaid payments, and access to rare disease and gene therapy drugs. Policies contained in drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021, and in H.R.3684 - Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act. Policies contained in 85 FR 87000, Medicaid Program; Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements.
HEALTH CARE SERVICE CORPORATION via CHAMBER HILL STRATEGIES
2022 · first_quarter · Q1
Issues related generally to: Medicare Advantage, Medicare Part D, and Medicaid managed care plans, including but not limited to policies related to social determinants of health, health equity, and maternal mortality, including policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021. Policies contained in P.L. 117-7, to prevent across-the-board direct spending cuts, and for other purposes, and P.L. 117-71, Protecting Medicare and American Farmers from Sequester Cuts Act. Policies contained in H.R.3684 - Infrastructure Investment and Jobs Act, and H.R. 5376, Build Back Better Act.
Issues related generally to: the Affordable Care Act, insurance markets/stabilization, transparency, surprise billing, access to and payment for mental health care, and COVID-19 response, including those contained in but not limited to policies in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030, and P.L. 117-103, the Consolidated Appropriations Act, 2022; and health care policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021. Policies contained in H.R.3684 - Infrastructure Investment and Jobs Act, and H.R. 5376, Build Back Better Act.
SOCIETY OF HOSPITAL MEDICINE via CHAMBER HILL STRATEGIES
2022 · first_quarter · Q1
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; H.R. 4521, America COMPETES Act of 2022; and policies contained in H.R. 5376, Build Back Better Act.
H.R. 3650/S.2048, Improving Access to Medicare Coverage Act of 2021; H.R. 3173/S. 3018, Improving Seniors Timely Access to Care Act of 2021; H.R. 7053/S.3792, Hospital Inpatient Services Modernization Act; policies related to physician payments in P.L. 116-260, the Consolidated Appropriations Act, 2021, P.L. 117-7, to prevent across-the-board direct spending cuts, P.L. 117-71, Protecting Medicare and American Farmers from Sequester Cuts Act and H.R. 6020/S. 3314, Supporting Medicare Providers Act of 2021; policies related to physicians contained in H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act; and policies related to telehealth in P.L. 117-103, the Consolidated Appropriations Act, 2022. Issues pertaining to physician payment, quality measurement, observation care, prior authorization and access to care through Medicare Advantage, generally; and policies in the CY2022 Medicare Physician Payment Fee Schedule rule.
SANFORD HEALTH via CHAMBER HILL STRATEGIES
2022 · first_quarter · Q1
Policies that affect hospitals and skilled nursing facilities in P.L. 117-103, the Consolidated Appropriations Act, 2022,, H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14; various value-based payment models at the Centers for Medicare and Medicaid Innovations.
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; and H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; policies contained in H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14.
NATIONAL ACADEMY OF ELDER LAW ATTORNEYS, INC. via CHAMBER HILL STRATEGIES
2022 · first_quarter · Q1
General education around long term services and supports, home and community-based services issues, spousal impoverishment, Medicaid eligibility in Section 1115 waivers, Money Follows the Person program; home and community services policies in H.R. 5376, Build Back Better Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAGHMOS THERAPEUTICS, INC. via CHAMBER HILL STRATEGIES
2021 · fourth_quarter · Q4
Policies to address health disparities in kidney disease, patient literacy, diversity in clinical trial participation, FDA/CMS communications, and Medicare payment modernization, generally, and related to H.R. 6000, Cures 2.0 Act. Education and awareness, regarding treatment of contrast-induced acute kidney injury after percutaneous coronary intervention.
Medicare beneficiary access to a potential treatment to prevent contrast-induced acute kidney injury and major adverse renal and cardiac events after percutaneous coronary intervention, as well as potential savings to Medicare and beneficiaries to such prevention.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL PARTNERSHIP FOR WOMEN AND FAMILIES via CHAMBER HILL STRATEGIES
2021 · fourth_quarter · Q4
General education around paid family, medical and sick leave issues; paid sick day policies in P.L. 117-2, the Consolidated Appropriations Act, 2021, H.R. 804/S. 248, the FAMILY Act; policies contained in H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOMARIN PHARMACEUTICAL INC. via CHAMBER HILL STRATEGIES
2021 · fourth_quarter · Q4
H.R. 785/S.2313, a bill for the relief of Maria Isabel Bueso Barrera, Alberto Bueso Mendoza, and Karla Maria Barrera De Bueso.
Issues generally related to biopharmaceutical drugs and drug development programs, including, but not limited to: Orphan Drug Act incentives, including H.R. 1629/S.250, the Fairness in Orphan Drug Exclusivity Act; drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021; access to rare disease and gene therapy drugs; and FDA approvals of drugs designed to treat rare diseases, including gene therapies. Issues pertaining to newborn screening and gene panel screening, including provisions of H.R. 482/S.350 , the Newborn Screening Saves Lives Reauthorization Act of 2021. Policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021. Policies contained in H.R.3684 - Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act.
HEALTH CARE SERVICE CORPORATION via CHAMBER HILL STRATEGIES
2021 · fourth_quarter · Q4
Issues related generally to: Medicare Advantage, Medicare Part D, and Medicaid managed care plans, including but not limited to policies related to social determinants of health, health equity, and maternal mortality, including policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021. Policies contained in P.L. 117-7, to prevent across-the-board direct spending cuts, and for other purposes, and P.L. 117-71, Protecting Medicare and American Farmers from Sequester Cuts Act. Policies contained in H.R.3684 - Infrastructure Investment and Jobs Act, and H.R. 5376, Build Back Better Act.
Issues related generally to: the Affordable Care Act, insurance markets/stabilization, transparency, surprise billing, and COVID-19 response, including those contained in but not limited to policies in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and health care policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021. Policies contained in H.R.3684 - Infrastructure Investment and Jobs Act, and H.R. 5376, Build Back Better Act.
SOCIETY OF HOSPITAL MEDICINE via CHAMBER HILL STRATEGIES
2021 · fourth_quarter · Q4
H.R. 3650/S.2048, Improving Access to Medicare Coverage Act of 2021; H.R. 3173, Improving Seniors Timely Access to Care Act of 2021; policies related to physician payments in P.L. 116-260, the Consolidated Appropriations Act, 2021, P.L. 117-7, to prevent across-the-board direct spending cuts P.L. 117-71, Protecting Medicare and American Farmers from Sequester Cuts Act and H.R. 6020/S. 3314, Supporting Medicare Provider Act of 2021; policies related to physicians contained in H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act; issues pertaining to physician payment, quality measurement and observation care, generally; and policies in the CY2022 Medicare Physician Payment Fee Schedule rule.
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; and H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; policies contained in H.R. 5376, Build Back Better Act.
NATIONAL ACADEMY OF ELDER LAW ATTORNEYS, INC. via CHAMBER HILL STRATEGIES
2021 · fourth_quarter · Q4
General education around long term services and supports, home and community-based services issues, spousal impoverishment, Medicaid eligibility in Section 1115 waivers; extension of Money Follows the Person program in P.L. 117-2, the Consolidated Appropriations Act, 2021; policies in H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
LOGAN HEALTH (FORMALLY KNOWN AS KALISPELL REGIONAL HEALTHCARE) via CHAMBER HILL STRATEGIES
2021 · fourth_quarter · Q4
Policies that affect hospitals in P.L. 117-2, the Consolidated Appropriations Act, 2021, H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN BURN ASSOCIATION via CHAMBER HILL STRATEGIES
2021 · fourth_quarter · Q4
Patient safety policies related to home oxygen therapy.
Continued FY 2022 funding for the Military Burn Research Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANFORD HEALTH via CHAMBER HILL STRATEGIES
2021 · fourth_quarter · Q4
Policies that affect hospitals and skilled nursing facilities in P.L. 117-2, the Consolidated Appropriations Act, 2021, H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14; various value-based payment models at the Centers for Medicare and Medicaid Innovations.
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; and H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; policies contained in H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14.
LOGAN HEALTH (FORMALLY KNOWN AS KALISPELL REGIONAL HEALTHCARE) via CHAMBER HILL STRATEGIES
2021 · third_quarter · Q3
Policies that affect hospitals in P.L. 117-2, the Consolidated Appropriations Act, 2021, H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAGHMOS THERAPEUTICS, INC. via CHAMBER HILL STRATEGIES
2021 · third_quarter · Q3
Medicare beneficiary access to a potential treatment to prevent contrast-induced acute kidney injury and major adverse renal and cardiac events after percutaneous coronary intervention, as well as potential savings to Medicare and beneficiaries to such prevention.
Policies to address health disparities in kidney disease, patient literacy, diversity in clinical trial participation, FDA/CMS communications, and Medicare payment modernization, generally, and related to the 21st Century Cures 2.0 Discussion Draft. Education and awareness, regarding treatment of contrast-induced acute kidney injury after percutaneous coronary intervention.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL PARTNERSHIP FOR WOMEN AND FAMILIES via CHAMBER HILL STRATEGIES
2021 · third_quarter · Q3
General education around paid family, medical and sick leave issues; paid sick day policies in P.L. 117-2, the Consolidated Appropriations Act, 2021, H.R. 804/S. 248, the FAMILY Act; policies contained in H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN BURN ASSOCIATION via CHAMBER HILL STRATEGIES
2021 · third_quarter · Q3
Patient safety policies related to home oxygen therapy.
Continued FY 2022 funding for the Military Burn Research Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOMARIN PHARMACEUTICAL INC. via CHAMBER HILL STRATEGIES
2021 · third_quarter · Q3
Issues generally related to the Orphan Drug Tax Credit, including provisions in H,R. 2623, Camerons Law and H.R. 5376, To provide for reconciliation pursuant to title II of S. Con. Res. 14.
Issues generally related to biopharmaceutical drugs and drug development programs, including but not limited to drug pricing proposals, Medicaid payments, and access to rare disease and gene therapy drugs. Policies contained in drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021, and in H.R.3684 - Infrastructure Investment and Jobs Act and H.R. 5376, To provide for reconciliation pursuant to title II of S. Con. Res. 14. Policies contained in 85 FR 87000, Medicaid Program; Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements.
HEALTH CARE SERVICE CORPORATION via CHAMBER HILL STRATEGIES
2021 · third_quarter · Q3
Issues related generally to: Medicare Advantage, Medicare Part D, and Medicaid managed care plans, including but not limited to policies related to social determinants of health, health equity, and maternal mortality, including policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021. Policies contained in P.L. 117-7, to prevent across-the-board direct spending cuts, and for other purposes. Policies contained in in H.R.3684 - Infrastructure Investment and Jobs Act and H.R. 5376, To provide for reconciliation pursuant to title II of S. Con. Res. 14.
Issues related generally to: the Affordable Care Act, insurance markets/stabilization, transparency, surprise billing, and COVID-19 response, including those contained in but not limited to policies in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and health care policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021. Policies contained in H.R.3684 - Infrastructure Investment and Jobs Act and H.R. 5376, To provide for reconciliation pursuant to title II of S. Con. Res. 14.
SOCIETY OF HOSPITAL MEDICINE via CHAMBER HILL STRATEGIES
2021 · third_quarter · Q3
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; and H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; policies contained in H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14.
H.R. 3650/S.2048, Improving Access to Medicare Coverage Act of 2021; H.R. 3173, Improving Seniors Timely Access to Care Act of 2021; policies related to physician payments in P.L. 116-260, the Consolidated Appropriations Act, 2021 and P.L. 117-7, to prevent across-the-board direct spending cuts; policies related to physicians contained in H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14; issues pertaining to physician payment, quality measurement and observation care, generally; and policies in the CY2022 Medicare Physician Payment Fee Schedule rule.
SANFORD HEALTH via CHAMBER HILL STRATEGIES
2021 · third_quarter · Q3
Policies that affect hospitals in P.L. 117-2, the Consolidated Appropriations Act, 2021, H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14; various value-based payment models at the Centers for Medicare and Medicaid Innovations.
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act; H.R. 3648, Equal Access to Green cards for Legal Employment Act of 2021 or the EAGLE Act of 2021; and H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act; policies contained in H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ACADEMY OF ELDER LAW ATTORNEYS, INC. via CHAMBER HILL STRATEGIES
2021 · third_quarter · Q3
General education around long term services and supports, home and community-based services issues, spousal impoverishment, Medicaid eligibility in Section 1115 waivers; extension of Money Follows the Person program in P.L. 117-2, the Consolidated Appropriations Act, 2021; policies in H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PEAK INTERNATIONAL PARTNERS LLC via CHAMBER HILL STRATEGIES
2021 · second_quarter · Q2
Personal protective equipment
Personal protective equipment
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
LOGAN HEALTH (FORMALLY KNOWN AS KALISPELL REGIONAL HEALTHCARE) via CHAMBER HILL STRATEGIES
2021 · second_quarter · Q2
Policies that affect hospitals in P.L. 117-2, the Consolidated Appropriations Act, 2021, and various legislative proposals to improve infrastructure.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAGHMOS THERAPEUTICS, INC. via CHAMBER HILL STRATEGIES
2021 · second_quarter · Q2
Policies intended to help address racial disparities in kidney disease, particularly those pertaining to patient literacy, diversity in clinical trial participation, FDA/CMS communications, and Medicare payment modernization, generally, and for consideration for inclusion in the 21st Century Cures 2.0 Discussion Draft. Education and awareness, generally, regarding treatment of contrast-induced acute kidney injury after percutaneous coronary intervention.
Medicare beneficiary access to a potential treatment to prevent contrast-induced acute kidney injury and major adverse renal and cardiac events after percutaneous coronary intervention, as well as potential savings to Medicare and beneficiaries to such prevention.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN RENAL ASSOCIATES via CHAMBER HILL STRATEGIES
2021 · second_quarter · 2T
Issues pertaining to access to, coverage of, and reimbursement for kidney care, including charitable premium assistance, kidney disease education, and anti-kickback issues. Issues pertaining to the COVID-19 response, including but not limited to the vaccination of kidney patients and providers. Policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021.
Issues pertaining to access to, coverage of and reimbursement for dialysis services and kidney care, including integrated and coordinated care, including but not limited to H.R. 8254/S. 4574, the Bringing Enhanced Treatments and Therapies to ESRD Recipients (BETTER) Kidney Care Act (116th Congress). Issues pertaining to administrative proposals for new value-based purchasing models for dialysis services; policies contained in 85 FR 33796, Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program. Policies contained in P.L. 117-7, to prevent across-the-board direct spending cuts, and for other purposes.
NATIONAL PARTNERSHIP FOR WOMEN AND FAMILIES via CHAMBER HILL STRATEGIES
2021 · second_quarter · Q2
General education around paid family, medical and sick leave issues; paid sick day policies in P.L. 117-2, the Consolidated Appropriations Act, 2021, H.R. 804/S. 248, the FAMILY Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN BURN ASSOCIATION via CHAMBER HILL STRATEGIES
2021 · second_quarter · Q2
Continued FY 2022 funding for the Military Burn Research Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOMARIN PHARMACEUTICAL INC. via CHAMBER HILL STRATEGIES
2021 · second_quarter · Q2
Issues generally related to the Orphan Drug Tax Credit, including provisions in H,R. 2623, Camerons Law.
Issues generally related to biopharmaceutical drugs and drug development programs, including but not limited to drug pricing proposals, Medicaid payments, and access to rare disease and gene therapy drugs. Policies contained in 85 FR 87000, Medicaid Program; Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements.
HEALTH CARE SERVICE CORPORATION via CHAMBER HILL STRATEGIES
2021 · second_quarter · Q2
Issues related generally to: Medicare Advantage, Medicare Part D, and Medicaid managed care plans, including but not limited to policies related to social determinants of health, health equity, and maternal mortality, including policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021. Policies contained in P.L. 117-7, to prevent across-the-board direct spending cuts, and for other purposes.
Issues related generally to: the Affordable Care Act, insurance markets/stabilization, transparency, surprise billing, and COVID-19 response, including those contained in but not limited policies in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and health care policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021.
SOCIETY OF HOSPITAL MEDICINE via CHAMBER HILL STRATEGIES
2021 · second_quarter · Q2
Implementation of P.L. 114-10, the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA); policies related to observation care status, generally, and proposals related to satisfying the three-day inpatient hospital stay requirement with respect to Medicare coverage of skilled nursing facility services, including H.R. 3650/S.2048, Improving Access to Medicare Coverage Act of 2021.; and policies contained in P.L. 117-7 , to prevent across-the-board direct spending cuts, and for other purposes.
H.R. 1384/S. 445, the Mainstreaming Addiction Treatment Act of 2019. Health care policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and health care policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021.
NATIONAL ACADEMY OF ELDER LAW ATTORNEYS, INC. via CHAMBER HILL STRATEGIES
2021 · second_quarter · Q2
General education around long term services and supports, home and community-based services issues, spousal impoverishment, Medicaid eligibility in Section 1115 waivers; extension of Money Follows the Person program in P.L. 117-2, the Consolidated Appropriations Act, 2021.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COVENANT HEALTHCARE via CHAMBER HILL STRATEGIES
2021 · second_quarter · Q2
Policies that affect hospitals in P.L. 117-2, the Consolidated Appropriations Act, 2021, and various legislative proposals to improve infrastructure.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PEAK INTERNATIONAL PARTNERS LLC via CHAMBER HILL STRATEGIES
2021 · second_quarter · RR
Personal protective equipment
LOGAN HEALTH (FORMALLY KNOWN AS KALISPELL REGIONAL HEALTHCARE) via CHAMBER HILL STRATEGIES
2021 · first_quarter · Q1
Policies that affect hospitals in P.L. 117-2, the Consolidated Appropriations Act, 2021.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN RENAL ASSOCIATES via CHAMBER HILL STRATEGIES
2021 · first_quarter · Q1
Issues pertaining to access to, coverage of and reimbursement for dialysis services and kidney care, including integrated and coordinated care, including but not limited to H.R. 8254/S. 4574, the Bringing Enhanced Treatments and Therapies to ESRD Recipients (BETTER) Kidney Care Act (116th Congress). Issues pertaining to administrative proposals for new value-based purchasing models for dialysis services; policies contained in 85 FR 33796, Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program. Policies contained in and amendments to H.R.1868, to prevent across-the-board direct spending cuts, and for other purposes.
Issues pertaining to access to, coverage of, and reimbursement for kidney care, including charitable premium assistance, kidney disease education, and anti-kickback issues. Issues pertaining to the COVID-19 response, including but not limited to the vaccination of kidney patients and providers. Policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021.
NATIONAL PARTNERSHIP FOR WOMEN AND FAMILIES via CHAMBER HILL STRATEGIES
2021 · first_quarter · Q1
General education around paid family, medical and sick leave issues; paid sick day policies in P.L. 117-2, the Consolidated Appropriations Act, 2021, H.R. 804/S. 248, the FAMILY Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN BURN ASSOCIATION via CHAMBER HILL STRATEGIES
2021 · first_quarter · Q1
Continued FY 2022 funding for the Military Burn Research Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOMARIN PHARMACEUTICAL INC. via CHAMBER HILL STRATEGIES
2021 · first_quarter · Q1
Issues generally related to biopharmaceutical drugs and drug development programs, including, but not limited to: Orphan Drug Act incentives; drug pricing proposals; access to rare disease and gene therapy drugs; and FDA approvals of drugs designed to treat rare diseases, including gene therapies. Issues pertaining to newborn screening and gene panel screening, including, H.R. 2507, the Newborn Screening Saves Lives Reauthorization Act of 2019 and S. 2158, the Newborn Screening Saves Lives Reauthorization Act of 2019 (116th Congress). Policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021.
H.R. 785, for the relief of Maria Isabel Bueso Barrera, Alberto Bueso Mendoza, and Karla Maria Barrera De Bueso. Policies contained in S. 2612, For the relief of Maria Isabel Bueso Barrera, Alberto Bueso Mendoza, Karla Maria Barrera De Bueso, and Ana Lucia Bueso Barrera (116th Congress).
HEALTH CARE SERVICE CORPORATION via CHAMBER HILL STRATEGIES
2021 · first_quarter · Q1
Issues related generally to: Medicare Advantage, Medicare Part D, and Medicaid managed care plans, including but not limited to maternal mortality, including policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021. Policies contained in and amendments to H.R.1868, to prevent across-the-board direct spending cuts, and for other purposes.
Issues related generally to: the Affordable Care Act, insurance markets/stabilization, transparency, surprise billing, and COVID-19 response, including those contained in but not limited policies in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and health care policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021.
SOCIETY OF HOSPITAL MEDICINE via CHAMBER HILL STRATEGIES
2021 · first_quarter · Q1
H.R. 1384/S. 445, the Mainstreaming Addiction Treatment Act of 2019. Health care policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and health care policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021.
Implementation of P.L. 114-10, the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA); policies related to observation care status, generally, and proposals related to satisfying the three-day inpatient hospital stay requirement with respect to Medicare coverage of skilled nursing facility services.; and policies contained in and amendments to H.R.1868, to prevent across-the-board direct spending cuts, and for other purposes.
NATIONAL ACADEMY OF ELDER LAW ATTORNEYS, INC. via CHAMBER HILL STRATEGIES
2021 · first_quarter · Q1
General education around long term services and supports, home and community-based services issues, spousal impoverishment, Medicaid eligibility in Section 1115 waivers; extension of Money Follows the Person program in P.L. 117-2, the Consolidated Appropriations Act, 2021.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COVENANT HEALTHCARE via CHAMBER HILL STRATEGIES
2021 · first_quarter · Q1
Policies that affect hospitals in P.L. 117-2, the Consolidated Appropriations Act, 2021.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FREQUENCY THERAPEUTICS INC. via CHAMBER HILL STRATEGIES
2020 · fourth_quarter · 4T
Issues related to hearing health and hearing restoration.
Issues related to hearing health and hearing restoration.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LOGAN HEALTH (FORMALLY KNOWN AS KALISPELL REGIONAL HEALTHCARE) via CHAMBER HILL STRATEGIES
2020 · fourth_quarter · Q4
Policies that affect hospitals in P.L. 116-123, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, the Families First Coronavirus Response Act; P.L. 116-136, the Coronavirus Aid, Relief and Economic Security Act; and P.L. 116-139, the Paycheck Protection Program and Health Care Enhancement Act; H.R. 6800, the Heroes Act; H.R. 8406, the Heroes Act; Senate Amendment 2652 related to COVID-19 relief; P.L. 116-159, the Continuing Appropriations Act, 2021 and Other Extensions Act; and P.L. 116-260, Consolidated Appropriations Act, 2021.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAGHMOS THERAPEUTICS, INC. via CHAMBER HILL STRATEGIES
2020 · fourth_quarter · Q4
Issues related to the policies proposed in the 21st Century Cures 2.0 Concept Paper. Education and awareness, generally, regarding treatment of contrast-induced acute kidney injury after percutaneous coronary intervention. Education regarding outpatient treatment protocols for at home care of COVID-19.
Medicare beneficiary access to a potential treatment to prevent contrast-induced acute kidney injury and major adverse renal and cardiac events after percutaneous coronary intervention, as well as potential savings to Medicare and beneficiaries to such prevention.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN RENAL ASSOCIATES via CHAMBER HILL STRATEGIES
2020 · fourth_quarter · Q4
Issues pertaining to access to, coverage of, and reimbursement for kidney care, including charitable premium assistance, kidney disease education, and anti-kickback issues.
Issues pertaining to access to, coverage of and reimbursement for dialysis services and kidney care, including integrated and coordinated care, including but not limited to H.R. 8254/S. 4574, the Bringing Enhanced Treatments and Therapies to ESRD Recipients (BETTER) Kidney Care Act. Issues pertaining to administrative proposals for new value-based purchasing models for dialysis services; policies contained in 85 FR 33796, Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program. Health care policies in P.L. 116-123, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, the Families First Coronavirus Response Act; P.L. 116-136, the Coronavirus Aid, Relief, and Economic Security Act of CARES Act; and P.L. 116-139, the Paycheck Protection Program and Health Care Enhancement Act; H.R. 6800, the Heroes Act; H.R. 8406, the Heroes Act; Senate Amendment 2652 related to COVID-19 relief; P.L. 116-159, the Continuing Appropriations Act, 2021 and Other Extensions Act; and P.L.116-260, Consolidated Appropriations Act, 2021.
NATIONAL PARTNERSHIP FOR WOMEN AND FAMILIES via CHAMBER HILL STRATEGIES
2020 · fourth_quarter · Q4
General education around paid family, medical and sick leave issues; H.R.1185 and S.463, the Family and Medical Insurance Leave Act; S.1174 and H.R.1534, Federal Employee Paid Leave Act; S.2976 and H.R. 5296, Advancing Support for Working Families Act; P.L. 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, Families First Coronavirus Response Act; P.L. 116-136,Coronavirus Aid, Relief, and Economic Security Act; H.R.6150 and S.3415, Paid Sick Days for Public Health Emergencies and Personal and Family Care Act; S.3513, Providing Americans Insured Days of Leave Act of 2020; P.L. 116-139, the Paycheck Protection Program and Health Care Enhancement Act; S.4049/H.R.6395, National Defense Authorization Act for Fiscal Year 2021; H.R.6800, The Heroes Act; H.R.8337,Continuing Appropriations Act, 2021 and Other Extensions Act; S.4775, Delivering Immediate Relief to America's Families, Schools and Small Businesses Act; H.R. 8406, the Heroes Act; Senate Amendment 2652 related to COVID-19 relief; P.L. 116-159, the Continuing Appropriations Act, 2021 and Other Extensions Act; and P.L.116-260, Consolidated Appropriations Act, 2021.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN BURN ASSOCIATION via CHAMBER HILL STRATEGIES
2020 · fourth_quarter · Q4
H.R.806/S.1640, the Portable Fuel Container Safety Act of 2019.
Continued funding for the Military Burn Research Program through FY 2021 Department of Defense Appropriations Act, including continued funding through P.L. 116-159, the Continuing Appropriations Act, 2021 and Other Extensions Act, and P.L.116-260, Consolidated Appropriations Act, 2021.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOMARIN PHARMACEUTICAL INC. via CHAMBER HILL STRATEGIES
2020 · fourth_quarter · Q4
Issues generally related to biopharmaceutical drugs and drug development programs, including but not limited to drug pricing proposals, Medicaid payments, and access to rare disease and gene therapy drugs. Policies proposed in 85 FR 37286, Medicaid Program; Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements.
H.R. 4225, For the relief of Maria Isabel Bueso Barrera, Alberto Bueso Mendoza, Karla Maria Barrera De Bueso, and Ana Lucia Bueso Barrera, and S. 2612, For the relief of Maria Isabel Bueso Barrera, Alberto Bueso Mendoza, Karla Maria Barrera De Bueso, and Ana Lucia Bueso Barrera.
HEALTH CARE SERVICE CORPORATION via CHAMBER HILL STRATEGIES
2020 · fourth_quarter · Q4
Issues related generally to: Medicare Advantage, Medicare Part D, and Medicaid managed care plans, including but not limited to opioid prescribing and use, and maternal mortality, including H.R. 4996, Helping MOMS Act of 2019, and policies contained in H.R. 6800, the Heroes Act; H.R. 1425, the Patient Protection and Affordable Care Enhancement Act; H.R. 8406, the Heroes Act; Senate Amendment 2652 related to COVID-19 relief; and P.L. 116-159, the Continuing Appropriations Act, 2021 and Other Extensions Act; Health care policies contained in and related to P.L.116-260, Consolidated Appropriations Act, 2021; P.L. 116-123, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, the Families First Coronavirus Response Act; P.L. 116-136, the Coronavirus Aid, Relief, and Economic Security Act of CARES Act; and P.L. 116-139, the Paycheck Protection Program and Health Care Enhancement Act, and P.L. 115-271, the SUPPORT for Patients and Communities Act.
Issues related generally to: the Affordable Care Act, insurance markets, stabilization, transparency, surprise billing, and COVID-19 response, including those contained in but not limited to: H.R. 6800, the Heroes Act; H.R. 8406, the Heroes Act; Senate Amendment 2652 related to COVID- 19 relief; and P.L. 116-159, the Continuing Appropriations Act, 2021 and Other Extensions Act; H.R. 1425, the Patient Protection and Affordable Care Enhancement Act; S. 1895, the Lower Health Care Costs Act; H.R. 3630, the No Surprises Act; H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act of 2020,; and H.R. 5800, the Ban Surprise Billing Act; Health care policies contained in and related to P.L.116-260, Consolidated Appropriations Act, 2021; P.L. 116-123, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, the Families First Coronavirus Response Act; P.L. 116-136, the Coronavirus Aid, Relief, and Economic Security Act of CARES Act; and P.L. 116-139, the Paycheck Protection Program and Health Care Enhancement Act.
SOCIETY OF HOSPITAL MEDICINE via CHAMBER HILL STRATEGIES
2020 · fourth_quarter · Q4
H.R. 1044/S. 386, the Fairness for High-Skilled Immigrants Act of 2019; H.R. 2895/S. 948, the Conrad State 30 and Physician Access Reauthorization Act; H.R. 6788/S. 3599, the Healthcare Workforce Resilience Act; issues relating to the Presidents Proclamation Suspending Entry of Aliens Who Present a Risk to the U.S. Labor Market Following the Coronavirus Outbreak (dated June 22, 2020); and issues pertaining to add issues pertaining to Establishing a Fixed Time Period of Admission and an Extension of Stay Procedure for Nonimmigrant Academic Students, Exchange Visitors, and Representatives of Foreign Information Media (DHS Docket No. ICEB-2019-0006).
Implementation of P.L. 114-10, the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), including but not limited to issues concerning Qualifying APM Participant (QP) thresholds and H.R. 7791, Value in Health Care Act of 2020; Policies contained in H.R. 1682/S. 753, the Improving Access to Medicare Coverage Act of 2019 and S. 1260, Reducing Administrative Costs and Burdens in Health Care Act of 2019; Issues concerning changes to the Medicare Part B physician fee schedule in the proposed rule, CY2021 Payment Polices under the Physician Fee Schedule and Other Changes to Part B Payment Policies (CMS-1734-P) and H.R.8702 - Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020; Health care policies in P.L. 116-123, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, the Families First Coronavirus Response Act; P.L. 116-136, the Coronavirus Aid, Relief, and Economic Security Act of CARES Act; P.L. 116-139, the Paycheck Protection Program and Health Care Enhancement Act; H.R. 6800, the Heroes Act; H.R. 8406, the Heroes Act; Senate Amendment 2652 related to COVID-19 relief; P.L.116-159, the Continuing Appropriations Act, 2021 and Other Extensions Act.; and P.L.116-260, Consolidated Appropriations Act, 2021.
NATIONAL ACADEMY OF ELDER LAW ATTORNEYS, INC. via CHAMBER HILL STRATEGIES
2020 · fourth_quarter · Q4
General education around long term services and supports and home and community-based services issues; P.L. 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, Families First Coronavirus Response Act; P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act; S.3544 and H.R.6305, Coronavirus Relief for Seniors and People with Disabilities Act of 2020;S.3277, HCBS Infrastructure Improvement Act; P.L. 116-139, the Paycheck Protection Program and Health Care Enhancement Act; S.3768, Nursing Home COVID-19 Protection and Prevention Act of 2020; H.R. 6800, the Heroes Act; H.R. 8406, the Heroes Act; Senate Amendment 2652 related to COVID-19 relief; P.L. 116-159, the Continuing Appropriations Act, 2021 and Other Extensions Act; and P.L. 116-260, Consolidated Appropriations Act, 2021.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COVENANT HEALTHCARE via CHAMBER HILL STRATEGIES
2020 · fourth_quarter · Q4
Policies that affect hospitals in P.L. 116-123, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, the Families First Coronavirus Response Act; P.L. 116-136, the Coronavirus Aid, Relief and Economic Security Act; and P.L. 116-139, the Paycheck Protection Program and Health Care Enhancement Act; H.R. 6800, the Heroes Act; H.R. 8406, the Heroes Act; Senate Amendment 2652 related to COVID-19 relief; P.L. 116-159, the Continuing Appropriations Act, 2021 and Other Extensions Act; and P.L. 116-260, Consolidated Appropriations Act, 2021.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL PARTNERSHIP FOR WOMEN AND FAMILIES via CHAMBER HILL STRATEGIES
2020 · third_quarter · Q3
General education around paid family, medical and sick leave issues; H.R.1185 and S.463, the Family and Medical Insurance Leave Act; S.1174 and H.R.1534, Federal Employee Paid Leave Act; S.2976 and H.R. 5296, Advancing Support for Working Families Act; P.L. 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, Families First Coronavirus Response Act; P.L. 116-136, Coronavirus Aid, Relief, and Economic Security (CARES) Act; H.R.6150 and S.3415, Paid Sick Days for Public Health Emergencies and Personal and Family Care Act; S.3513, Providing Americans Insured Days of Leave Act of 2020; P.L. 116-139, the Paycheck Protection Program and Health Care Enhancement Act; S.4049/H.R.6395, National Defense Authorization Act for Fiscal Year 2021; H.R.6800, The Heroes Act; H.R.8337, Continuing Appropriations Act, 2021 and Other Extensions Act; S.4775, Delivering Immediate Relief to America's Families, Schools and Small Businesses Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ACADEMY OF ELDER LAW ATTORNEYS, INC. via CHAMBER HILL STRATEGIES
2020 · third_quarter · Q3
General education around long term services and supports and home and community-based services issues; P.L. 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, Families First Coronavirus Response Act; P.L. 116-136, Coronavirus Aid, Relief, and Economic Security (CARES) Act; S.3544 and H.R.6305, Coronavirus Relief for Seniors and People with Disabilities Act of 2020; S.3277, HCBS Infrastructure Improvement Act; P.L. 116-139, the Paycheck Protection Program and Health Care Enhancement Act; S.3768, Nursing Home COVID-19 Protection and Prevention Act of 2020; H.R.6800, The Heroes Act; H.R.8337, Continuing Appropriations Act, 2021 and Other Extensions Act; S.4775, Delivering Immediate Relief to America's Families, Schools and Small Businesses Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SAGHMOS THERAPEUTICS, INC. via CHAMBER HILL STRATEGIES
2020 · third_quarter · Q3
Medicare beneficiary access to a potential treatment to prevent contrast-induced acute kidney injury and major adverse renal and cardiac events after percutaneous coronary intervention, as well as potential savings to Medicare and beneficiaries to such prevention.
Issues related to the policies proposed in the 21st Century Cures 2.0 Concept Paper. Education and awareness, generally, regarding treatment of contrast-induced acute kidney injury after percutaneous coronary intervention.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTH AND HOSPITALS, INC. via CHAMBER HILL STRATEGIES
2020 · third_quarter · 3T
Issues related to hospital area wage index; policies that affect hospitals in P.L. 116-123, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, the Families First Coronavirus Response Act; P.L. 116-136, the Coronavirus Aid, Relief and Economic Security Act; and P.L. 116-139, the Paycheck Protection Program and Health Care Enhancement Act; H.R. 8406, the Heroes Act; Senate Amendment 2652 related to COVID-19 relief; and H.R. 8337, the Continuing Appropriations Act, 2021 and Other Extensions Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN RENAL ASSOCIATES via CHAMBER HILL STRATEGIES
2020 · third_quarter · Q3
Issues pertaining to: access to, coverage of and reimbursement for dialysis services and kidney care, including integrated and coordinated care, including but not limited to H.R. 8254/S. 4574, the Bringing Enhanced Treatments and Therapies to ESRD Recipients (BETTER) Kidney Care Act. Issues pertaining to administrative proposals for new value-based purchasing models for dialysis services; COVID-19 relief for and response by providers; and policies contained in 85 FR 33796, Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program. Health care policies in P.L. 116-123, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, the Families First Coronavirus Response Act; P.L. 116-136, the Coronavirus Aid, Relief, and Economic Security Act of CARES Act; and P.L. 116-139, the Paycheck Protection Program and Health Care Enhancement Act; H.R. 6800, the Heroes Act; H.R. 8406, the Heroes Act; Senate Amendment 2652 related to COVID-19 relief; and H.R. 8337, the Continuing Appropriations Act, 2021 and Other Extensions Act.
AMERICAN BURN ASSOCIATION via CHAMBER HILL STRATEGIES
2020 · third_quarter · Q3
H.R.806/S.1640, the Portable Fuel Container Safety Act of 2019.
Continued funding for the Military Burn Research Program through FY 2021 Department of Defense Appropriations Act, including continued funding through H.R. 8337, the Continuing Appropriations Act, 2021 and Other Extensions Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOMARIN PHARMACEUTICAL INC. via CHAMBER HILL STRATEGIES
2020 · third_quarter · Q3
Issues generally related to the Orphan Drug Tax Credit.
Issues generally related to biopharmaceutical drugs and drug development programs, including, but not limited to: Orphan Drug Act incentives; drug pricing proposals; access to rare disease and gene therapy drugs, including S. 2543, The Prescription Drug Pricing Reduction Act of 2019, H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, H.R. 19, the Lower Costs, More Cures Act of 2019, H.R. 5882, the GENE Therapy Payment Act, and H.R. 4439, Creating Hope Reauthorization Act; newborn screening and gene panel screening, including, H.R. 2507, the Newborn Screening Saves Lives Reauthorization Act of 2019 and S. 2158, the Newborn Screening Saves Lives Reauthorization Act of 2019; and FDA approvals of drugs designed to treat rare diseases. Health care policies in P.L. 116- 123, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, the Families First Coronavirus Response Act; P.L. 116-136, the Coronavirus Aid, Relief, and Economic Security Act of CARES Act; P.L. 116-139, the Paycheck Protection Program and Health Care Enhancement Act; H.R. 6800, the Heroes Act; H.R. 8406, the Heroes Act; Senate Amendment 2652 related to COVID-19 relief; and H.R. 8337, the Continuing Appropriations Act, 2021 and Other Extensions Act.
HEALTH CARE SERVICE CORPORATION via CHAMBER HILL STRATEGIES
2020 · third_quarter · Q3
Issues related generally to: the Affordable Care Act, insurance markets, stabilization, transparency, surprise billing, and COVID-19 response, including those contained in but not limited to: H.R. 6800, the Heroes Act; H.R. 8406, the Heroes Act; Senate Amendment 2652 related to COVID-19 relief; and H.R. 8337, the Continuing Appropriations Act, 2021 and Other Extensions Act; H.R. 1425, the Patient Protection and Affordable Care Enhancement Act; S. 1895, the Lower Health Care Costs Act; H.R. 3630, the No Surprises Act; H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act of 2020,; and H.R. 5800, the Ban Surprise Billing Act. Health care policies in P.L. 116-123, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, the Families First Coronavirus Response Act; P.L. 116-136, the Coronavirus Aid, Relief, and Economic Security Act of CARES Act; and P.L. 116-139, the Paycheck Protection Program and Health Care Enhancement Act.
Issues related generally to: Medicare Advantage, Medicare Part D, and Medicaid managed care plans, including but not limited to opioid prescribing and use, and maternal mortality, including H.R. 4996, Helping MOMS Act of 2019, and policies contained in H.R. 6800, the Heroes Act; H.R. 1425, the Patient Protection and Affordable Care Enhancement Act; H.R. 8406, the Heroes Act; Senate Amendment 2652 related to COVID-19 relief; and H.R. 8337, the Continuing Appropriations Act, 2021 and Other Extensions Act. Health care policies in P.L. 116-123, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, the Families First Coronavirus Response Act; P.L. 116-136, the Coronavirus Aid, Relief, and Economic Security Act of CARES Act; and P.L. 116-139, the Paycheck Protection Program and Health Care Enhancement Act, and P.L. 115-271, the SUPPORT for Patients and Communities Act.
SOCIETY OF HOSPITAL MEDICINE via CHAMBER HILL STRATEGIES
2020 · third_quarter · Q3
H.R. 1044/S. 386, the Fairness for High-Skilled Immigrants Act of 2019; H.R. 2895/S. 948, the Conrad State 30 and Physician Access Reauthorization Act; H.R. 6788/S. 3599, the Healthcare Workforce Resilience Act; and issues relating to the Presidents Proclamation Suspending Entry of Aliens Who Present a Risk to the U.S. Labor Market Following the Coronavirus Outbreak (dated June 22, 2020).
Implementation of P.L. 114-10, the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), including but not limited to issues concerning Qualifying APM Participant (QP) thresholds and H.R. 7791, Value in Health Care Act of 2020. Policies contained in H.R. 1682/S. 753, the Improving Access to Medicare Coverage Act of 2019; H.R. 2482/S. 2074, the Mainstreaming Addiction Treatment Act of 2019; and S. 1260, Reducing Administrative Costs and Burdens in Health Care Act of 2019. Issues concerning changes to the Medicare Part B physician fee schedule in the proposed rule, CY2021 Payment Polices under the Physician Fee Schedule and Other Changes to Part B Payment Policies (CMS-1734-P). Health care policies in P.L. 116-123, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, the Families First Coronavirus Response Act; P.L. 116-136, the Coronavirus Aid, Relief, and Economic Security Act of CARES Act; P.L. 116-139, the Paycheck Protection Program and Health Care Enhancement Act; H.R. 6800, the Heroes Act; H.R. 8406, the Heroes Act; Senate Amendment 2652 related to COVID-19 relief; and H.R. 8337, the Continuing Appropriations Act, 2021 and Other Extensions Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues generally related to biopharmaceutical drugs and drug development programs, including, but not limited to: Orphan Drug Act incentives, including H.R. 1629/S.250, the Fairness in Orphan Drug Exclusivity Act; drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021; access to rare disease and gene therapy drugs; education and awareness of genetic rare bone disorders; FDA approvals of drugs designed to treat rare diseases, including gene therapies; and regulatory reforms generally, including but not limited to S. 3799, the PREVENT Pandemics Act, H.R. 6000, CURES 2.0, H.R. 6963, the Accelerated Approval Integrity Act of 2022, H.R. 6996, the Accelerating Access for Patients Act; H.R. 7667, Food and Drug Amendments of 2022, and S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act. Issues pertaining to newborn screening and gene panel screening, including provisions of H.R. 482/S.350 , the Newborn Screening Saves Lives Reauthorization Act of 2021. Policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021; P.L. 117-169, Inflation Reduction Act.
H.R. 785/S.2313, a bill for the relief of Maria Isabel Bueso Barrera, Alberto Bueso Mendoza, and Karla Maria Barrera De Bueso.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H.R. 1384/S. 445, the Mainstreaming Addiction Treatment Act of 2019; H.R. 7666, Restoring Hope for Mental Health and Well Being Act of 2022; issues generally pertaining to the impact of COVID-19 on hospitalists.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues generally related to biopharmaceutical drugs and drug development programs, including but not limited to drug pricing proposals, Medicaid payments, access to treatment through telehealth, and access to rare disease and gene therapy drugs. Policies contained in drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021. Policies contained in 85 FR 87000, Medicaid Program; Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements. H.R. 7489, Medicaid VBPs for Patients Act or the MVP Act.
Issues generally related to the Orphan Drug Tax Credit, including provisions in H,R. 2623, Camerons Law and H.R. 5376, Build Back Better Act.
Policies contained in H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H.R. 785/S.2313, a bill for the relief of Maria Isabel Bueso Barrera, Alberto Bueso Mendoza, and Karla Maria Barrera De Bueso.
Issues generally related to the Orphan Drug Tax Credit, including provisions in H,R. 2623, Camerons Law and H.R. 5376, Build Back Better Act.
Policies contained in H.R.3684, Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H.R. 1384/S. 445, the Mainstreaming Addiction Treatment Act of 2019; H.R. 7666, Restoring Hope for Mental Health and Well Being Act of 2022; issues generally pertaining to the impact of COVID-19 on hospitalists.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues generally related to biopharmaceutical drugs and drug development programs, including, but not limited to: Orphan Drug Act incentives, including H.R. 1629/S.250, the Fairness in Orphan Drug Exclusivity Act; drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021; access to rare disease and gene therapy drugs; FDA approvals of drugs designed to treat rare diseases, including gene therapies; and regulatory reforms generally, including but not limited to S. 3799, the PREVENT Pandemics Act, H.R. 6000, CURES 2.0, H.R. 6963, the Accelerated Approval Integrity Act of 2022, H.R. 6996, the Accelerating Access for Patients Act. Issues pertaining to newborn screening and gene panel screening, including provisions of H.R. 482/S.350 , the Newborn Screening Saves Lives Reauthorization Act of 2021. Policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021.
Issues generally related to the Orphan Drug Tax Credit, including provisions in H,R. 2623, Camerons Law and H.R. 5376, Build Back Better Act.
H.R. 785/S.2313, a bill for the relief of Maria Isabel Bueso Barrera, Alberto Bueso Mendoza, and Karla Maria Barrera De Bueso.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H.R. 1384/S. 445, the Mainstreaming Addiction Treatment Act of 2019; H.R. 1667, Dr. Lorna Breen Health Care Provider Protection Act/ P.L. 117- 71, Protecting Medicare and American Farmers from Sequester Cuts Act; issues generally pertaining to the impact of COVID on hospitalists.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 6000, Cures 2.0 Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues generally related to biopharmaceutical drugs and drug development programs, including but not limited to drug pricing proposals, Medicaid payments, and access to rare disease and gene therapy drugs. Policies contained in drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021, and in H.R.3684 - Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act. Policies contained in 85 FR 87000, Medicaid Program; Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements.
Issues generally related to the Orphan Drug Tax Credit, including provisions in H,R. 2623, Camerons Law and H.R. 5376, Build Back Better Act.
Policies contained in H.R.3684 - Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act. Consideration of issues pertaining to PKU patients lost to follow up to be included in FY 2022 Labor, Health and Human Services, Education and Related Agencies funding bills.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H.R. 1384/S. 445, the Mainstreaming Addiction Treatment Act of 2019; H.R. 1667, Dr. Lorna Breen Health Care Provider Protection Act/ P.L. 117-71, Protecting Medicare and American Farmers from Sequester Cuts Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 6000, Cures 2.0 Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Policies contained in H.R.3684 - Infrastructure Investment and Jobs Act and H.R. 5376, To provide for reconciliation pursuant to title II of S. Con. Res. 14. Consideration of issues pertaining to PKU patients lost to follow up to be included in FY 2022 Labor, Health and Human Services, Education and Related Agencies funding bills.
H.R. 785/S.2313, a bill for the relief of Maria Isabel Bueso Barrera, Alberto Bueso Mendoza, and Karla Maria Barrera De Bueso.
Issues generally related to biopharmaceutical drugs and drug development programs, including, but not limited to: Orphan Drug Act incentives, including H.R. 1629/S.250, the Fairness in Orphan Drug Exclusivity Act; drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021; access to rare disease and gene therapy drugs; and FDA approvals of drugs designed to treat rare diseases, including gene therapies. Issues pertaining to newborn screening and gene panel screening, including provisions of H.R. 482/S.350 , the Newborn Screening Saves Lives Reauthorization Act of 2021. Policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021. Policies contained in H.R.3684 - Infrastructure Investment and Jobs Act and H.R. 5376, To provide for reconciliation pursuant to title II of S. Con. Res. 14.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H.R. 1384/S. 445, the Mainstreaming Addiction Treatment Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues generally related to biopharmaceutical drugs and drug development programs, including, but not limited to: Orphan Drug Act incentives, including H.R. 1629/S.250, the Fairness in Orphan Drug Exclusivity Act; drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021; access to rare disease and gene therapy drugs; and FDA approvals of drugs designed to treat rare diseases, including gene therapies. Issues pertaining to newborn screening and gene panel screening, including provisions of H.R. 482/S.350 , the Newborn Screening Saves Lives Reauthorization Act of 2021. Policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021.
Consideration of issues pertaining to PKU patients lost to follow up to be included in FY 2022 Labor, Health and Human Services, Education and Related Agencies funding bills.
H.R. 785, for the relief of Maria Isabel Bueso Barrera, Alberto Bueso Mendoza, and Karla Maria Barrera De Bueso. Policies contained in S. 2612, For the relief of Maria Isabel Bueso Barrera, Alberto Bueso Mendoza, Karla Maria Barrera De Bueso, and Ana Lucia Bueso Barrera (116th Congress).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H.R. 2255/ S.1024-Healthcare Workforce Resilience Act Policies contained in H.R. 3648, To amend the Immigration and Nationality Act to eliminate the per-country numerical limitation for employment-based immigrants, to increase the per-country numerical limitation for family-sponsored immigrants, and for other purposes; and H.R. 3541/S. 1810, Conrad State 30 and Physician Access Reauthorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Consideration of issues pertaining to PKU patients lost to follow up to be included in FY 2022 Labor, Health and Human Services, Education and Related Agencies funding bills.
Issues generally related to biopharmaceutical drugs and drug development programs, including but not limited to drug pricing proposals, Medicaid payments, and access to rare disease and gene therapy drugs. Policies proposed in 85 FR 87000, Medicaid Program; Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements.
Issues generally related to the Orphan Drug Tax Credit.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H.R. 2255/ S.1024 - A bill to enhance our Nation's nurse and physician workforce during the COVID-19 crisis by recapturing unused immigrant visas. Policies contained in H.R. 1044/S. 386, the Fairness for High-Skilled Immigrants Act of 2019 and H.R. 2895/S. 948, the Conrad State 30 and Physician Access Reauthorization Act (116th Congress).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues generally related to biopharmaceutical drugs and drug development programs, including, but not limited to: Orphan Drug Act incentives; drug pricing proposals; access to rare disease and gene therapy drugs, including S. 2543, The Prescription Drug Pricing Reduction Act of 2019, H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, H.R. 19, the Lower Costs, More Cures Act of 2019, H.R. 5882, the GENE Therapy Payment Act, and H.R. 4439, Creating Hope Reauthorization Act; newborn screening and gene panel screening, including, H.R. 2507, the Newborn Screening Saves Lives Reauthorization Act of 2019 and S. 2158, the Newborn Screening Saves Lives Reauthorization Act of 2019; H.R. 4439, Creating Hope Reauthorization Act; and FDA approvals of drugs designed to treat rare diseases; Health care policies in P.L. 116- 123, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, the Families First Coronavirus Response Act; P.L. 116-136, the Coronavirus Aid, Relief, and Economic Security Act of CARES Act; P.L. 116-139, the Paycheck Protection Program and Health Care Enhancement Act; H.R. 6800, the Heroes Act; H.R. 8406, the Heroes Act; Senate Amendment 2652 related to COVID-19 relief; P.L. 116-159, the Continuing Appropriations Act, 2021 and Other Extensions Act; and P.L.116-260, Consolidated Appropriations Act, 2021.
Issues generally related to the Orphan Drug Tax Credit.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H.R. 2482/S. 2074, the Mainstreaming Addiction Treatment Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues pertaining to access to, coverage of, and reimbursement for kidney care; including charitable premium assistance, kidney disease education, and anti-kick back issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H.R. 4225, For the relief of Maria Isabel Bueso Barrera, Alberto Bueso Mendoza, Karla Maria Barrera De Bueso, and Ana Lucia Bueso Barrera, and S. 2612, For the relief of Maria Isabel Bueso Barrera, Alberto Bueso Mendoza, Karla Maria Barrera De Bueso, and Ana Lucia Bueso Barrera.
Issues generally related to: biopharmaceutical drugs and drug development programs, including but not limited to drug pricing proposals, Medicaid payments, and access to rare disease and gene therapy drugs. Policies proposed in 85 FR 37286, Medicaid Program; Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE